KR102605832B1 - Compound and organic light emitting device comprising same - Google Patents
Compound and organic light emitting device comprising same Download PDFInfo
- Publication number
- KR102605832B1 KR102605832B1 KR1020210007505A KR20210007505A KR102605832B1 KR 102605832 B1 KR102605832 B1 KR 102605832B1 KR 1020210007505 A KR1020210007505 A KR 1020210007505A KR 20210007505 A KR20210007505 A KR 20210007505A KR 102605832 B1 KR102605832 B1 KR 102605832B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- compound
- substituted
- unsubstituted
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 196
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 78
- 125000004432 carbon atom Chemical group C* 0.000 claims description 73
- 229910052805 deuterium Inorganic materials 0.000 claims description 69
- 125000003118 aryl group Chemical group 0.000 claims description 61
- 238000002347 injection Methods 0.000 claims description 54
- 239000007924 injection Substances 0.000 claims description 54
- 125000000217 alkyl group Chemical group 0.000 claims description 32
- 239000011368 organic material Substances 0.000 claims description 31
- 229910052739 hydrogen Inorganic materials 0.000 claims description 24
- 239000001257 hydrogen Substances 0.000 claims description 24
- 125000000623 heterocyclic group Chemical group 0.000 claims description 23
- 230000005525 hole transport Effects 0.000 claims description 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 16
- 238000006467 substitution reaction Methods 0.000 claims description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- 125000000732 arylene group Chemical group 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 239000002019 doping agent Substances 0.000 claims description 7
- 125000001624 naphthyl group Chemical group 0.000 claims description 6
- 125000004957 naphthylene group Chemical group 0.000 claims description 5
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 description 190
- 238000003786 synthesis reaction Methods 0.000 description 190
- 239000010410 layer Substances 0.000 description 123
- 239000000463 material Substances 0.000 description 48
- -1 1-methylpentyl group Chemical group 0.000 description 30
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 125000001424 substituent group Chemical group 0.000 description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 18
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Natural products C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 16
- 125000001072 heteroaryl group Chemical group 0.000 description 14
- 239000012044 organic layer Substances 0.000 description 14
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 14
- 239000012153 distilled water Substances 0.000 description 13
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 12
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 238000004440 column chromatography Methods 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical group C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 9
- 125000003277 amino group Chemical group 0.000 description 9
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 8
- 238000004770 highest occupied molecular orbital Methods 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 229910052782 aluminium Inorganic materials 0.000 description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 7
- 125000006267 biphenyl group Chemical group 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- HUMMCEUVDBVXTQ-UHFFFAOYSA-N naphthalen-1-ylboronic acid Chemical compound C1=CC=C2C(B(O)O)=CC=CC2=C1 HUMMCEUVDBVXTQ-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 6
- 125000002950 monocyclic group Chemical group 0.000 description 6
- 125000003367 polycyclic group Chemical group 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000010409 thin film Substances 0.000 description 6
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 229940125797 compound 12 Drugs 0.000 description 5
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- 125000005561 phenanthryl group Chemical group 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 4
- PYXBCVWIECUMDW-UHFFFAOYSA-N 2-bromoanthracene Chemical compound C1=CC=CC2=CC3=CC(Br)=CC=C3C=C21 PYXBCVWIECUMDW-UHFFFAOYSA-N 0.000 description 4
- WAXYLWVPOVKZED-UHFFFAOYSA-N 4-bromo-3-fluorodibenzofuran Chemical compound Fc1ccc2c3ccccc3oc2c1Br WAXYLWVPOVKZED-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000010405 anode material Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000005241 heteroarylamino group Chemical group 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 3
- 239000010406 cathode material Substances 0.000 description 3
- 229940125773 compound 10 Drugs 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 229940125898 compound 5 Drugs 0.000 description 3
- 229920001940 conductive polymer Polymers 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 125000005509 dibenzothiophenyl group Chemical group 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 229910052741 iridium Inorganic materials 0.000 description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 3
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 3
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920000553 poly(phenylenevinylene) Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 3
- 125000001725 pyrenyl group Chemical group 0.000 description 3
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 125000003960 triphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C3=CC=CC=C3C12)* 0.000 description 3
- YDMRDHQUQIVWBE-UHFFFAOYSA-N (2-hydroxyphenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1O YDMRDHQUQIVWBE-UHFFFAOYSA-N 0.000 description 2
- GGZASRFCRAZNPO-UHFFFAOYSA-N (5-chloro-2-hydroxyphenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=CC=C1O GGZASRFCRAZNPO-UHFFFAOYSA-N 0.000 description 2
- UVNPEUJXKZFWSJ-LMTQTHQJSA-N (R)-N-[(4S)-8-[6-amino-5-[(3,3-difluoro-2-oxo-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-yl]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)N[C@@H]1COCC11CCN(CC1)c1cnc(Sc2ccnc3NC(=O)C(F)(F)c23)c(N)n1 UVNPEUJXKZFWSJ-LMTQTHQJSA-N 0.000 description 2
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 2
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- VBQVHWHWZOUENI-UHFFFAOYSA-N 1-phenyl-2H-quinoline Chemical compound C1C=CC2=CC=CC=C2N1C1=CC=CC=C1 VBQVHWHWZOUENI-UHFFFAOYSA-N 0.000 description 2
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 2
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- XQVWYOYUZDUNRW-UHFFFAOYSA-N N-Phenyl-1-naphthylamine Chemical group C=1C=CC2=CC=CC=C2C=1NC1=CC=CC=C1 XQVWYOYUZDUNRW-UHFFFAOYSA-N 0.000 description 2
- NUGPIZCTELGDOS-QHCPKHFHSA-N N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclopentanecarboxamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CC[C@@H](C=1C=NC=CC=1)NC(=O)C1CCCC1)C NUGPIZCTELGDOS-QHCPKHFHSA-N 0.000 description 2
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 2
- 229910003813 NRa Inorganic materials 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000005103 alkyl silyl group Chemical group 0.000 description 2
- 125000005577 anthracene group Chemical group 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 2
- 125000005104 aryl silyl group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 125000003914 fluoranthenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC=C4C1=C23)* 0.000 description 2
- 229910052733 gallium Inorganic materials 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000005549 heteroarylene group Chemical group 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- UEEXRMUCXBPYOV-UHFFFAOYSA-N iridium;2-phenylpyridine Chemical compound [Ir].C1=CC=CC=C1C1=CC=CC=N1.C1=CC=CC=C1C1=CC=CC=N1.C1=CC=CC=C1C1=CC=CC=N1 UEEXRMUCXBPYOV-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- KPTRDYONBVUWPD-UHFFFAOYSA-N naphthalen-2-ylboronic acid Chemical compound C1=CC=CC2=CC(B(O)O)=CC=C21 KPTRDYONBVUWPD-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 2
- JCDAUYWOHOLVMH-UHFFFAOYSA-N phenanthren-9-ylboronic acid Chemical compound C1=CC=C2C(B(O)O)=CC3=CC=CC=C3C2=C1 JCDAUYWOHOLVMH-UHFFFAOYSA-N 0.000 description 2
- 238000005240 physical vapour deposition Methods 0.000 description 2
- 229920000767 polyaniline Polymers 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- TVIVIEFSHFOWTE-UHFFFAOYSA-K tri(quinolin-8-yloxy)alumane Chemical compound [Al+3].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 TVIVIEFSHFOWTE-UHFFFAOYSA-K 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- UKSZBOKPHAQOMP-SVLSSHOZSA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 UKSZBOKPHAQOMP-SVLSSHOZSA-N 0.000 description 1
- HPTKHPAGOMESFW-UHFFFAOYSA-N (2-chloro-6-hydroxyphenyl)boronic acid Chemical compound OB(O)C1=C(O)C=CC=C1Cl HPTKHPAGOMESFW-UHFFFAOYSA-N 0.000 description 1
- XBNRJKSGOLRSRX-UHFFFAOYSA-N (4-chloro-2-hydroxyphenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1O XBNRJKSGOLRSRX-UHFFFAOYSA-N 0.000 description 1
- GGTUVWGMCFXUAS-UHFFFAOYSA-N (5-chloro-2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=CC=C1F GGTUVWGMCFXUAS-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- FXEGEEUPPGLIIC-UHFFFAOYSA-N 1-bromo-3-fluoro-2-iodobenzene Chemical compound FC1=CC=CC(Br)=C1I FXEGEEUPPGLIIC-UHFFFAOYSA-N 0.000 description 1
- NHDODQWIKUYWMW-UHFFFAOYSA-N 1-bromo-4-chlorobenzene Chemical compound ClC1=CC=C(Br)C=C1 NHDODQWIKUYWMW-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- VFMUXPQZKOKPOF-UHFFFAOYSA-N 2,3,7,8,12,13,17,18-octaethyl-21,23-dihydroporphyrin platinum Chemical compound [Pt].CCc1c(CC)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(CC)c5CC)c(CC)c4CC)c(CC)c3CC VFMUXPQZKOKPOF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- VWVRASTUFJRTHW-UHFFFAOYSA-N 2-[3-(azetidin-3-yloxy)-4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound O=C(CN1C=C(C(OC2CNC2)=N1)C1=CN=C(NC2CC3=C(C2)C=CC=C3)N=C1)N1CCC2=C(C1)N=NN2 VWVRASTUFJRTHW-UHFFFAOYSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- NPHULPIAPWNOOH-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(2,3-dihydroindol-1-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCC2=CC=CC=C12 NPHULPIAPWNOOH-UHFFFAOYSA-N 0.000 description 1
- IKOKHHBZFDFMJW-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(2-morpholin-4-ylethoxy)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)OCCN1CCOCC1 IKOKHHBZFDFMJW-UHFFFAOYSA-N 0.000 description 1
- XXZCIYUJYUESMD-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(morpholin-4-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCOCC1 XXZCIYUJYUESMD-UHFFFAOYSA-N 0.000 description 1
- WWSJZGAPAVMETJ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethoxypyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)OCC WWSJZGAPAVMETJ-UHFFFAOYSA-N 0.000 description 1
- LPZOCVVDSHQFST-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CC LPZOCVVDSHQFST-UHFFFAOYSA-N 0.000 description 1
- HVTQDSGGHBWVTR-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-phenylmethoxypyrazol-1-yl]-1-morpholin-4-ylethanone Chemical compound C(C1=CC=CC=C1)OC1=NN(C=C1C=1C=NC(=NC=1)NC1CC2=CC=CC=C2C1)CC(=O)N1CCOCC1 HVTQDSGGHBWVTR-UHFFFAOYSA-N 0.000 description 1
- FYELSNVLZVIGTI-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-5-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1CC)CC(=O)N1CC2=C(CC1)NN=N2 FYELSNVLZVIGTI-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- JVKRKMWZYMKVTQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JVKRKMWZYMKVTQ-UHFFFAOYSA-N 0.000 description 1
- VXZBYIWNGKSFOJ-UHFFFAOYSA-N 2-[4-[5-(2,3-dihydro-1H-inden-2-ylamino)pyrazin-2-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC=1N=CC(=NC=1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 VXZBYIWNGKSFOJ-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- OWFINXQLBMJDJQ-UHFFFAOYSA-N 2-chloroanthracene Chemical compound C1=CC=CC2=CC3=CC(Cl)=CC=C3C=C21 OWFINXQLBMJDJQ-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- WONYVCKUEUULQN-UHFFFAOYSA-N 2-methyl-n-(2-methylphenyl)aniline Chemical group CC1=CC=CC=C1NC1=CC=CC=C1C WONYVCKUEUULQN-UHFFFAOYSA-N 0.000 description 1
- JTMODJXOTWYBOZ-UHFFFAOYSA-N 2-methyl-n-phenylaniline Chemical group CC1=CC=CC=C1NC1=CC=CC=C1 JTMODJXOTWYBOZ-UHFFFAOYSA-N 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- DDTHMESPCBONDT-UHFFFAOYSA-N 4-(4-oxocyclohexa-2,5-dien-1-ylidene)cyclohexa-2,5-dien-1-one Chemical compound C1=CC(=O)C=CC1=C1C=CC(=O)C=C1 DDTHMESPCBONDT-UHFFFAOYSA-N 0.000 description 1
- MGGVALXERJRIRO-UHFFFAOYSA-N 4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-2-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-1H-pyrazol-5-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)O MGGVALXERJRIRO-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- QXDWMAODKPOTKK-UHFFFAOYSA-N 9-methylanthracen-1-amine Chemical group C1=CC(N)=C2C(C)=C(C=CC=C3)C3=CC2=C1 QXDWMAODKPOTKK-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- HAMJKNXGNVFDSJ-UHFFFAOYSA-N C1=2C(=CC(=C(C=2OC2=C1C=CC=C2)Br)F)Cl Chemical compound C1=2C(=CC(=C(C=2OC2=C1C=CC=C2)Br)F)Cl HAMJKNXGNVFDSJ-UHFFFAOYSA-N 0.000 description 1
- CXMTYFDOFZVCRQ-UHFFFAOYSA-N C1=C(C(=C2C(=C1)OC1=C2C=CC=C1)Br)F Chemical compound C1=C(C(=C2C(=C1)OC1=C2C=CC=C1)Br)F CXMTYFDOFZVCRQ-UHFFFAOYSA-N 0.000 description 1
- HWWDCIYPALTSJH-UHFFFAOYSA-N CC(C1=C2CC3=CC=CC=C13)=C(C)C(F)=C2Br Chemical compound CC(C1=C2CC3=CC=CC=C13)=C(C)C(F)=C2Br HWWDCIYPALTSJH-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical group CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NFTRAGGUIJBGHD-UHFFFAOYSA-N N-(9H-fluoren-1-yl)phenanthren-1-amine Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC1=2)NC1=CC=CC=2C3=CC=CC=C3CC1=2 NFTRAGGUIJBGHD-UHFFFAOYSA-N 0.000 description 1
- 125000006614 N-arylalkylamine group Chemical group 0.000 description 1
- ACYWVHCCUGTDEW-UHFFFAOYSA-N N-naphthalen-1-yl-9H-fluoren-1-amine Chemical group C1(=CC=CC2=CC=CC=C12)NC1=CC=CC=2C3=CC=CC=C3CC12 ACYWVHCCUGTDEW-UHFFFAOYSA-N 0.000 description 1
- WJOZUXJBWJTHQQ-UHFFFAOYSA-N N-phenyl-2-(2-phenylphenyl)aniline Chemical group C1(=CC=CC=C1)NC=1C(=CC=CC=1)C=1C(=CC=CC=1)C1=CC=CC=C1 WJOZUXJBWJTHQQ-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 1
- 101100451713 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HTL1 gene Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 125000005264 aryl amine group Chemical group 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- GQVWHWAWLPCBHB-UHFFFAOYSA-L beryllium;benzo[h]quinolin-10-olate Chemical compound [Be+2].C1=CC=NC2=C3C([O-])=CC=CC3=CC=C21.C1=CC=NC2=C3C([O-])=CC=CC3=CC=C21 GQVWHWAWLPCBHB-UHFFFAOYSA-L 0.000 description 1
- 125000006616 biphenylamine group Chemical group 0.000 description 1
- UFVXQDWNSAGPHN-UHFFFAOYSA-K bis[(2-methylquinolin-8-yl)oxy]-(4-phenylphenoxy)alumane Chemical compound [Al+3].C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC([O-])=CC=C1C1=CC=CC=C1 UFVXQDWNSAGPHN-UHFFFAOYSA-K 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001716 carbazoles Chemical class 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- XOYLJNJLGBYDTH-UHFFFAOYSA-M chlorogallium Chemical compound [Ga]Cl XOYLJNJLGBYDTH-UHFFFAOYSA-M 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 150000004826 dibenzofurans Chemical class 0.000 description 1
- XCIQGLJEEKGMRM-UHFFFAOYSA-N dibenzothiophen-2-ol Chemical compound C1=CC=C2C3=CC(O)=CC=C3SC2=C1 XCIQGLJEEKGMRM-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical group C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 229910003437 indium oxide Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- XNUVVHVFAAQPQY-UHFFFAOYSA-L manganese(2+) quinolin-8-olate Chemical compound N1=CC=CC2=CC=CC(=C12)[O-].[Mn+2].N1=CC=CC2=CC=CC(=C12)[O-] XNUVVHVFAAQPQY-UHFFFAOYSA-L 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000004776 molecular orbital Methods 0.000 description 1
- NJVSFOMTEFOHMI-UHFFFAOYSA-N n,2-diphenylaniline Chemical group C=1C=CC=C(C=2C=CC=CC=2)C=1NC1=CC=CC=C1 NJVSFOMTEFOHMI-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HCISEFFYVMEPNF-UHFFFAOYSA-N n-phenyl-9h-fluoren-1-amine Chemical group C=12CC3=CC=CC=C3C2=CC=CC=1NC1=CC=CC=C1 HCISEFFYVMEPNF-UHFFFAOYSA-N 0.000 description 1
- UMGBMWFOGBJCJA-UHFFFAOYSA-N n-phenylphenanthren-1-amine Chemical group C=1C=CC(C2=CC=CC=C2C=C2)=C2C=1NC1=CC=CC=C1 UMGBMWFOGBJCJA-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 125000005184 naphthylamino group Chemical group C1(=CC=CC2=CC=CC=C12)N* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 150000002964 pentacenes Chemical class 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- FVDOBFPYBSDRKH-UHFFFAOYSA-N perylene-3,4,9,10-tetracarboxylic acid Chemical compound C=12C3=CC=C(C(O)=O)C2=C(C(O)=O)C=CC=1C1=CC=C(C(O)=O)C2=C1C3=CC=C2C(=O)O FVDOBFPYBSDRKH-UHFFFAOYSA-N 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 125000001828 phenalenyl group Chemical group C1(C=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 150000003220 pyrenes Chemical class 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- YYMBJDOZVAITBP-UHFFFAOYSA-N rubrene Chemical compound C1=CC=CC=C1C(C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C(C=2C=CC=CC=2)=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 YYMBJDOZVAITBP-UHFFFAOYSA-N 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 150000003413 spiro compounds Chemical class 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- IBBLKSWSCDAPIF-UHFFFAOYSA-N thiopyran Chemical compound S1C=CC=C=C1 IBBLKSWSCDAPIF-UHFFFAOYSA-N 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- KWQNQSDKCINQQP-UHFFFAOYSA-K tri(quinolin-8-yloxy)gallane Chemical compound C1=CN=C2C(O[Ga](OC=3C4=NC=CC=C4C=CC=3)OC=3C4=NC=CC=C4C=CC=3)=CC=CC2=C1 KWQNQSDKCINQQP-UHFFFAOYSA-K 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WEHQTWMFKLIGEJ-UHFFFAOYSA-N triphenylen-1-amine Chemical group C1=CC=CC2=C3C(N)=CC=CC3=C(C=CC=C3)C3=C21 WEHQTWMFKLIGEJ-UHFFFAOYSA-N 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
- HTPBWAPZAJWXKY-UHFFFAOYSA-L zinc;quinolin-8-olate Chemical compound [Zn+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 HTPBWAPZAJWXKY-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/15—Hole transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
본 명세서는 화학식 1의 화합물 및 이를 포함하는 유기 발광 소자를 제공한다.This specification provides a compound of Formula 1 and an organic light-emitting device containing the same.
Description
본 명세서는 2020년 01월 20일 한국 특허청에 제출된 한국 특허 출원 제10-2020-0007436호의 출원일 이익을 주장하며, 그 내용 전부는 본 명세서에 포함된다.This specification claims the benefit of Korean Patent Application No. 10-2020-0007436 filed with the Korean Intellectual Property Office on January 20, 2020, the entire contents of which are included in this specification.
본 명세서는 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다.This specification relates to compounds and organic light-emitting devices containing the same.
유기 발광 소자는 2개의 전극 사이에 유기박막을 배치시킨 구조를 가지고 있다. 이와 같은 구조의 유기 발광 소자에 전압이 인가되면, 2개의 전극으로부터 주입된 전자와 전공이 유기박막에서 결합하여 쌍을 이룬 후 소멸하면서 빛을 발하게 된다. 상기 유기박막은 필요에 따라 단층 또는 다층으로 구성될 수 있다.Organic light emitting devices have a structure in which an organic thin film is placed between two electrodes. When voltage is applied to an organic light-emitting device with this structure, electrons and holes injected from two electrodes combine in the organic thin film to form a pair and then annihilate, emitting light. The organic thin film may be composed of a single layer or multiple layers as needed.
유기 발광 소자에서 사용되는 물질로는 순수 유기 물질 또는 유기 물질과 금속이 착물을 이루는 착화합물이 대부분을 차지하고 있으며, 용도에 따라 정공주입 물질, 정공수송 물질, 발광 물질, 전자수송 물질, 전자주입 물질 등으로 구분될 수 있다. 여기서, 정공주입 물질이나 정공수송 물질로는 p-타입의 성질을 가지는 유기물질, 즉 쉽게 산화가 되고 산화시에 전기화학적으로 안정한 상태를 가지는 유기물이 주로 사용되고 있다. 한편, 전자주입 물질이나 전자수송 물질로는 n-타입 성질을 가지는 유기 물질, 즉 쉽게 환원이 되고 환원시에 전기화학적으로 안정한 상태를 가지는 유기물이 주로 사용되고 있다. 발광층 물질로는 p-타입 성질과 n-타입 성질을 동시에 가진 물질, 즉 산화와 환원 상태에서 모두 안정한 형태를 갖는 물질이 바람직하며, 정공 및 전자가 발광층에서 재결합하여 생성되는 엑시톤(exciton)이 형성되었을 때 이를 빛으로 전환하는 발광 효율이 높은 물질이 바람직하다.Most of the materials used in organic light-emitting devices are pure organic materials or complexes of organic materials and metals. Depending on the application, hole injection materials, hole transport materials, light-emitting materials, electron transport materials, electron injection materials, etc. It can be divided into: Here, organic materials with p-type properties, that is, organic materials that are easily oxidized and have an electrochemically stable state upon oxidation, are mainly used as hole injection materials or hole transport materials. Meanwhile, organic materials with n-type properties, that is, organic materials that are easily reduced and have an electrochemically stable state upon reduction, are mainly used as electron injection materials or electron transport materials. The emitting layer material is preferably a material that has both p-type and n-type properties, that is, a material that is stable in both oxidation and reduction states, and excitons are formed when holes and electrons recombine in the emitting layer. A material with high luminous efficiency that converts light into light is desirable.
유기 발광 소자의 성능, 수명 또는 효율을 향상시키기 위하여, 유기박막의 재료의 개발이 지속적으로 요구되고 있다.In order to improve the performance, lifespan, or efficiency of organic light-emitting devices, the development of organic thin film materials is continuously required.
본 명세서는 화합물 및 이를 포함하는 유기 발광 소자를 제공한다.This specification provides a compound and an organic light-emitting device containing the same.
본 명세서의 일 실시상태는 하기 화학식 1로 표시되는 화합물을 제공한다.An exemplary embodiment of the present specification provides a compound represented by the following formula (1).
[화학식 1][Formula 1]
상기 화학식 1에 있어서,In Formula 1,
R1 및 R2는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이고,R1 and R2 are the same or different from each other and are each independently hydrogen; heavy hydrogen; Substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group,
Az1 및 Az2 중 어느 하나는 -L10-Ar1이며, 나머지 하나는 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이고,Either Az1 or Az2 is -L10-Ar1, and the other is hydrogen; heavy hydrogen; Substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group,
L1, L2 및 L10은 서로 같거나 상이하고, 각각 독립적으로 직접결합; 또는 치환 또는 비치환된 아릴렌기이며,L1, L2 and L10 are the same or different from each other and are each independently directly bonded; Or a substituted or unsubstituted arylene group,
Ar1은 치환 또는 비치환된 아릴기이고,Ar1 is a substituted or unsubstituted aryl group,
Ar2는 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이며,Ar2 is a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
a는 0 내지 5의 정수이며, b는 0 내지 6의 정수이고,a is an integer from 0 to 5, b is an integer from 0 to 6,
a가 2 이상일 경우, 2 이상의 R1은 서로 같거나 상이하고,When a is 2 or more, 2 or more R1s are the same or different from each other,
b가 2 이상일 경우, 2 이상의 R2는 서로 같거나 상이하며,When b is 2 or more, 2 or more R2s are the same or different from each other,
*는 하기 화학식 2와 결합하고,* combines with Formula 2 below,
[화학식 2][Formula 2]
상기 화학식 2에 있어서,In Formula 2,
X는 O, S, NR, 또는 CR'R"이고,X is O, S, NR, or CR'R",
R, R', R" 및 R3는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이며,R, R', R" and R3 are the same or different from each other and are each independently hydrogen; deuterium; substituted or unsubstituted alkyl group; or substituted or unsubstituted aryl group,
c는 0 내지 4의 정수이고,c is an integer from 0 to 4,
c가 2 이상일 경우, 2 이상의 R3는 서로 같거나 상이하며,When c is 2 or more, 2 or more R3s are the same or different from each other,
*는 상기 화학식 1과 결합되는 위치이다.* is the position bonded to Formula 1 above.
본 명세서의 또 하나의 실시상태는 제1 전극; 상기 제1 전극과 대향하여 구비되는 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비되는 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상이 상기 화합물을 포함하는 것인 유기 발광 소자를 제공한다.Another embodiment of the present specification includes a first electrode; a second electrode provided opposite the first electrode; and an organic light emitting device comprising at least one organic material layer provided between the first electrode and the second electrode, wherein at least one layer of the organic material layer includes the compound.
본 명세서에 기재된 화합물은 유기 발광 소자의 유기물층의 재료로서 사용될 수 있다. 본 발명의 일 실시상태에 따른 화합물을 유기 발광 소자에 적용시, 소자의 정공 주입 특성과 전자 주입 및 이동을 개선되어, 발광 효율이 우수하고, 낮은 구동전압, 고효율 및 장수명을 갖는 유기 발광 소자를 얻을 수 있다. 구체적으로 본 명세서에 기재된 화합물은 안트라센의 2번 또는 3번 탄소 위치에 아릴(Ar1)이 결합되어 있으므로, 높은 HOMO(highest occupied molecular orbital) 준위를 가져 소자 내의 정공 주입 특성을 개선할 수 있으며, 안트라센의 9번 탄소 위치에 전자의 이동이 우수한 치환기가 결합되어 있으므로, 소자 내의 전자 주입 및 수송을 개선할 수 있다.The compounds described in this specification can be used as a material for the organic layer of an organic light-emitting device. When the compound according to an embodiment of the present invention is applied to an organic light emitting device, the hole injection characteristics and electron injection and movement of the device are improved, resulting in an organic light emitting device having excellent luminous efficiency, low driving voltage, high efficiency, and long lifespan. You can get it. Specifically, the compound described in this specification has an aryl (Ar1) bonded to the 2nd or 3rd carbon position of anthracene, so it has a high HOMO (highest occupied molecular orbital) level and can improve hole injection characteristics in the device. Since a substituent with excellent electron mobility is attached to the 9th carbon position, electron injection and transport within the device can be improved.
도 1 내지 3은 본 명세서의 일 실시상태에 따른 유기 발광 소자를 도시한 것이다.1 to 3 show an organic light emitting device according to an exemplary embodiment of the present specification.
이하 본 명세서에 대하여 더욱 상세히 설명한다. Hereinafter, this specification will be described in more detail.
본 명세서는 하기 화학식 1로 표시되는 화합물을 제공한다. This specification provides a compound represented by the following formula (1).
[화학식 1][Formula 1]
상기 화학식 1에 있어서,In Formula 1,
R1 및 R2는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이고,R1 and R2 are the same or different from each other and are each independently hydrogen; heavy hydrogen; Substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group,
Az1 및 Az2 중 어느 하나는 -L10-Ar1이며, 나머지 하나는 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이고,Either Az1 or Az2 is -L10-Ar1, and the other is hydrogen; heavy hydrogen; Substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group,
L1, L2 및 L10은 서로 같거나 상이하고, 각각 독립적으로 직접결합; 또는 치환 또는 비치환된 아릴렌기이며,L1, L2 and L10 are the same or different from each other and are each independently directly bonded; Or a substituted or unsubstituted arylene group,
Ar1은 치환 또는 비치환된 아릴기이고,Ar1 is a substituted or unsubstituted aryl group,
Ar2는 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이며,Ar2 is a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
a는 0 내지 5의 정수이며, b는 0 내지 6의 정수이고,a is an integer from 0 to 5, b is an integer from 0 to 6,
a가 2 이상일 경우, 2 이상의 R1은 서로 같거나 상이하고,When a is 2 or more, 2 or more R1s are the same or different from each other,
b가 2 이상일 경우, 2 이상의 R2는 서로 같거나 상이하며,When b is 2 or more, 2 or more R2s are the same or different from each other,
*는 하기 화학식 2와 결합하고,* combines with Formula 2 below,
[화학식 2][Formula 2]
상기 화학식 2에 있어서,In Formula 2,
X는 O, S, NR, 또는 CR'R"이고,X is O, S, NR, or CR'R",
R, R', R" 및 R3는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이며,R, R', R" and R3 are the same or different from each other and are each independently hydrogen; deuterium; substituted or unsubstituted alkyl group; or substituted or unsubstituted aryl group,
c는 0 내지 4의 정수이고,c is an integer from 0 to 4,
c가 2 이상일 경우, 2 이상의 R3는 서로 같거나 상이하며,When c is 2 or more, 2 or more R3s are the same or different from each other,
*는 상기 화학식 1과 결합되는 위치이다.* is the position bonded to Formula 1 above.
상기 화학식 1로 표시되는 화합물은 안트라센의 2번 또는 3번 탄소 위치에 치환 또는 비치환된 아릴기가 포함됨으로써, HOMO 에너지 준위가 상승되어 정공의 주입을 개선하는 효과를 나타낸다. 또한, 9번 위에 디벤조퓨란에 상기 화학식 2가 축합된 치환기를 포함함으로써 전자 이동이 용이해지므로, 전자의 주입을 개선하는 효과도 나타낸다. 따라서, 상기 화학식 1로 표시되는 화합물을 유기 발광 소자의 호스트로 적용시 정공 주입 및 전자 주입 효과가 모두 개선되는 효과를 나타낸다.The compound represented by Formula 1 contains a substituted or unsubstituted aryl group at the 2nd or 3rd carbon position of anthracene, thereby increasing the HOMO energy level and improving hole injection. In addition, by including the substituent in which the formula 2 is condensed in the dibenzofuran at position 9, electron transfer is facilitated, which also has the effect of improving electron injection. Therefore, when the compound represented by Formula 1 is applied as a host of an organic light emitting device, both hole injection and electron injection effects are improved.
본 명세서에 있어서, 안트라센의 2번 위치 및 9번 위치는 하기와 같다.In this specification, positions 2 and 9 of anthracene are as follows.
본 명세서에 있어서, 어떤 부분이 어떤 구성요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다.In this specification, when a part “includes” a certain component, this means that it may further include other components rather than excluding other components, unless specifically stated to the contrary.
본 명세서에 있어서 치환기의 예시들은 아래에서 설명하나, 이에 한정되는 것은 아니다.Examples of substituents in this specification are described below, but are not limited thereto.
상기 "치환"이라는 용어는 화합물의 탄소 원자에 결합된 수소 원자가 다른 치환기로 바뀌는 것을 의미하며, 치환되는 위치는 수소 원자가 치환되는 위치, 즉 치환기가 치환 가능한 위치라면 한정하지 않으며, 2 이상 치환되는 경우, 2 이상의 치환기는 서로 동일하거나 상이할 수 있다.The term "substitution" means that a hydrogen atom bonded to a carbon atom of a compound is changed to another substituent. The position to be substituted is not limited as long as it is the position where the hydrogen atom is substituted, that is, a position where the substituent can be substituted, and if two or more substituents are substituted. , two or more substituents may be the same or different from each other.
본 명세서에서 "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; 시아노기(-CN); 니트로기; 히드록시기; 카보닐기; 에스테르기; 이미드기; 아민기; 실릴기; 붕소기; 알콕시기; 알킬기; 시클로알킬기; 아릴기; 및 헤테로고리기로 이루어진 군에서 선택된 1 또는 2 이상의 치환기로 치환되었거나 상기 예시된 치환기 중 2 이상의 치환기가 연결된 치환기로 치환되거나, 또는 어떠한 치환기도 갖지 않는 것을 의미한다. 예컨대, "2 이상의 치환기가 연결된 치환기"는 바이페닐기일 수 있다. 즉, 바이페닐기는 아릴기일 수도 있고, 2개의 페닐기가 연결된 치환기로 해석될 수 있다.As used herein, the term “substituted or unsubstituted” refers to deuterium; halogen group; Cyano group (-CN); nitro group; hydroxyl group; carbonyl group; ester group; imide group; Amine group; silyl group; boron group; Alkoxy group; Alkyl group; Cycloalkyl group; Aryl group; and a heterocyclic group, or is substituted with a substituent in which two or more of the above-exemplified substituents are linked, or does not have any substituent. For example, “a substituent group in which two or more substituents are connected” may be a biphenyl group. That is, the biphenyl group may be an aryl group, or it may be interpreted as a substituent in which two phenyl groups are connected.
본 명세서에서 "치환 또는 비치환된"이라는 용어는 중수소; 알킬기 및 아릴기로 이루어진 군에서 선택된 1 이상의 치환기로 치환 또는 비치환되는 것을 의미한다.As used herein, the term “substituted or unsubstituted” refers to deuterium; It means being substituted or unsubstituted with one or more substituents selected from the group consisting of alkyl groups and aryl groups.
본 명세서에서, "치환 또는 비치환된"은 중수소; 탄소수 1 내지 20의 알킬기; 탄소수 6 내지 30의 아릴기; 및 탄소수 2 내지 30의 헤테로고리기로 이루어진 군으로부터 선택된 1 이상의 치환기로 치환 또는 비치환된되는 것을 의미한다.As used herein, “substituted or unsubstituted” refers to deuterium; an alkyl group having 1 to 20 carbon atoms; Aryl group having 6 to 30 carbon atoms; and substituted or unsubstituted with one or more substituents selected from the group consisting of heterocyclic groups having 2 to 30 carbon atoms.
본 명세서에 있어서, 할로겐기는 불소, 염소, 브롬 또는 요오드가 될 수 있다.In this specification, the halogen group may be fluorine, chlorine, bromine, or iodine.
본 명세서에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 30인 것이 바람직하다. 구체적인 예로는 메틸기, 에틸기, 프로필기, n-프로필기, 이소프로필기, 부틸기, n-부틸기, 이소부틸기, tert-부틸기, sec-부틸기, 1-메틸-부틸기, 1-에틸-부틸기, 펜틸기, n-펜틸기, 이소펜틸기, 네오펜틸기, tert-펜틸기, 헥실기, n-헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 4-메틸-2-펜틸기, 3,3-디메틸부틸기, 2-에틸부틸기, 헵틸기, n-헵틸기, 1-메틸헥실기 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the alkyl group may be straight chain or branched, and the number of carbon atoms is not particularly limited, but is preferably 1 to 30. Specific examples include methyl group, ethyl group, propyl group, n-propyl group, isopropyl group, butyl group, n-butyl group, isobutyl group, tert-butyl group, sec-butyl group, 1-methyl-butyl group, 1- Ethyl-butyl group, pentyl group, n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, hexyl group, n-hexyl group, 1-methylpentyl group, 2-methylpentyl group, 4-methyl- Examples include, but are not limited to, 2-pentyl group, 3,3-dimethylbutyl group, 2-ethylbutyl group, heptyl group, n-heptyl group, and 1-methylhexyl group.
본 명세서에 있어서, 시클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 30인 것이 바람직하며, 구체적으로 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실, 시클로헵틸, 시클로옥틸 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the cycloalkyl group is not particularly limited, but preferably has 3 to 30 carbon atoms, and specifically includes cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, etc., but is not limited thereto. .
본 명세서에 있어서, 상기 알콕시기는 직쇄, 분지쇄 또는 고리쇄일 수 있다. 알콕시기의 탄소수는 특별히 한정되지 않으나, 탄소수 1 내지 30인 것이 바람직하다. 구체적으로, 메톡시, 에톡시, n-프로폭시, 이소프로폭시, n-부톡시, 이소부톡시, tert-부톡시, sec-부톡시, n-펜틸옥시, 네오펜틸옥시, 이소펜틸옥시, n-헥실옥시, 3,3-디메틸부틸옥시, 2-에틸부틸옥시, n-옥틸옥시, n-노닐옥시, n-데실옥시 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the alkoxy group may be straight chain, branched chain, or ring chain. The number of carbon atoms of the alkoxy group is not particularly limited, but is preferably 1 to 30 carbon atoms. Specifically, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentyloxy, neopentyloxy, isopentyloxy, n. -Hexyloxy, 3,3-dimethylbutyloxy, 2-ethylbutyloxy, n-octyloxy, n-nonyloxy, n-decyloxy, etc., but is not limited thereto.
본 명세서에 있어서, 아민기는 -NH2; 알킬아민기; N-알킬아릴아민기; 아릴아민기; N-아릴헤테로아릴아민기; N-알킬헤테로아릴아민기 및 헤테로아릴아민기로 이루어진 군으로부터 선택될 수 있으며, 탄소수는 특별히 한정되지 않으나, 0 내지 30인 것이 바람직하다. 아민기의 구체적인 예로는 메틸아민기, 디메틸아민기, 에틸아민기, 디에틸아민기, 페닐아민기, 나프틸아민기, 비페닐아민기, 안트릴아민기, 9-메틸-안트릴아민기, 디페닐아민기, N-페닐나프틸아민기, 디톨릴아민기, N-페닐톨릴아민기, 트리페닐레닐아민기, N-페닐비페닐아민기, N-페닐나프틸아민기, N-비페닐나프틸아민기, N-나프틸플루오레닐아민기, N-페닐페난트릴아민기, N-바이페닐페난트릴아민기, N-페닐플루오레닐아민기, N-페닐터페닐아민기, N-페난트릴플루오레닐아민기, N-비페닐플루오레닐아민기 등이 있으나, 이에 한정되는 것은 아니다.In this specification, the amine group is -NH 2 ; Alkylamine group; N-alkylarylamine group; Arylamine group; N-arylheteroarylamine group; It may be selected from the group consisting of N-alkylheteroarylamine group and heteroarylamine group, and the number of carbon atoms is not particularly limited, but is preferably 0 to 30. Specific examples of amine groups include methylamine group, dimethylamine group, ethylamine group, diethylamine group, phenylamine group, naphthylamine group, biphenylamine group, anthrylamine group, and 9-methyl-anthrylamine group. , diphenylamine group, N-phenylnaphthylamine group, ditolylamine group, N-phenyltolylamine group, triphenylenylamine group, N-phenylbiphenylamine group, N-phenylnaphthylamine group, N- Biphenylnaphthylamine group, N-naphthylfluorenylamine group, N-phenylphenanthrylamine group, N-biphenylphenanthrylamine group, N-phenylfluorenylamine group, N-phenylterphenylamine group , N-phenanthrylfluorenylamine group, N-biphenylfluorenylamine group, etc., but are not limited thereto.
본 명세서에 있어서, N-알킬아릴아민기는 아민기의 N에 알킬기 및 아릴기가 치환된 아민기를 의미한다.In the present specification, N-alkylarylamine group refers to an amine group in which the N of the amine group is substituted with an alkyl group and an aryl group.
본 명세서에 있어서, N-아릴헤테로아릴아민기는 아민기의 N에 아릴기 및 헤테로아릴기가 치환된 아민기를 의미한다.In the present specification, N-arylheteroarylamine group refers to an amine group in which an aryl group and a heteroaryl group are substituted at the N of the amine group.
본 명세서에 있어서, N-알킬헤테로아릴아민기는 아민기의 N에 알킬기 및 헤테로아릴기가 치환된 아민기를 의미한다.In the present specification, N-alkylheteroarylamine group refers to an amine group in which the N of the amine group is substituted with an alkyl group and a heteroaryl group.
본 명세서에 있어서, 알킬아민기, N-아릴알킬아민기, N-알킬헤테로아릴아민기 중의 알킬기는 전술한 알킬기의 예시와 같다. In this specification, the alkyl groups in the alkylamine group, N-arylalkylamine group, and N-alkylheteroarylamine group are the same as the examples of the alkyl groups described above.
본 명세서에 있어서, 헤테로아릴아민기의 예로는 치환 또는 비치환된 모노헤테로아릴아민기, 또는 치환 또는 비치환된 디헤테로아릴아민기가 있다. 상기 헤테로아릴기가 2 이상을 포함하는 헤테로아릴아민기는 단환식 헤테로아릴기, 다환식 헤테로아릴기, 또는 단환식 헤테로아릴기와 다환식 헤테로아릴기를 동시에 포함할 수 있다. 예컨대, 상기 헤테로아릴아민기 중의 헤테로아릴기는 후술한 헤테로아릴기의 예시 중에서 선택될 수 있다.In the present specification, examples of the heteroarylamine group include a substituted or unsubstituted monoheteroarylamine group, or a substituted or unsubstituted diheteroarylamine group. The heteroarylamine group containing two or more heteroaryl groups may include a monocyclic heteroaryl group, a polycyclic heteroaryl group, or a monocyclic heteroaryl group and a polycyclic heteroaryl group simultaneously. For example, the heteroaryl group in the heteroarylamine group may be selected from examples of heteroaryl groups described below.
본 명세서에 있어서, N-아릴헤테로아릴아민기 및 N-알킬헤테로아릴아민기 중의 헤테로아릴기의 예시는 후술한 헤테로아릴기의 예시와 같다.In this specification, examples of heteroaryl groups among N-arylheteroarylamine groups and N-alkylheteroarylamine groups are the same as examples of heteroaryl groups described later.
본 명세서에 있어서, 실릴기는 알킬실릴기 또는 아릴실릴기일 수 있으며, 나아가 트리알킬실릴기 또는 트리아릴실릴기일 수 있다. 상기 실릴기의 탄소수는 특별히 한정되지 않으나, 1 내지 30인 것이 바람직하며, 알킬실릴기의 탄소수는 1 내지 30이고, 아릴실릴기의 탄소수는 5 내지 30일 수 있다. 구체적으로 트리메틸실릴기, 트리에틸실릴기, tert-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the silyl group may be an alkylsilyl group or an arylsilyl group, and may further be a trialkylsilyl group or a trialylsilyl group. The carbon number of the silyl group is not particularly limited, but is preferably 1 to 30, the alkylsilyl group may have 1 to 30 carbon atoms, and the arylsilyl group may have 5 to 30 carbon atoms. Specifically, it includes trimethylsilyl group, triethylsilyl group, tert-butyldimethylsilyl group, vinyldimethylsilyl group, propyldimethylsilyl group, triphenylsilyl group, diphenylsilyl group, phenylsilyl group, etc., but is not limited thereto. .
본 명세서에 있어서, 붕소기는 -BR100R101일 수 있으며, 상기 R100 및 R101은 같거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐; 니트릴기; 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기; 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 및 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기로 이루어진 군으로부터 선택될 수 있다.In the present specification, the boron group may be -BR 100 R 101 , where R 100 and R 101 are the same or different, and are each independently hydrogen; heavy hydrogen; halogen; Nitrile group; A substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms; A substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; and substituted or unsubstituted heteroaryl groups having 2 to 30 carbon atoms.
본 명세서에 있어서, 아릴기는 특별히 한정되지 않으나, 탄소수 6 내지 60, 예컨대 탄소수 6 내지 30인 것이 바람직하며, 상기 아릴기는 단환식 또는 다환식일 수 있다.In the present specification, the aryl group is not particularly limited, but preferably has 6 to 60 carbon atoms, for example, 6 to 30 carbon atoms, and the aryl group may be monocyclic or polycyclic.
상기 아릴기가 단환식 아릴기인 경우 탄소수는 특별히 한정되지 않으나, 탄소수 6 내지 60인 것이 바람직하다. 구체적으로 단환식 아릴기로는 페닐기, 비페닐기, 터페닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다.When the aryl group is a monocyclic aryl group, the number of carbon atoms is not particularly limited, but is preferably 6 to 60 carbon atoms. Specifically, the monocyclic aryl group may be a phenyl group, a biphenyl group, or a terphenyl group, but is not limited thereto.
상기 아릴기가 다환식 아릴기인 경우 탄소수는 특별히 한정되지 않으나. 탄소수 10 내지 60인 것이 바람직하다. 구체적으로 다환식 아릴기로는 나프틸기, 안트릴기, 페난트릴기, 트리페닐레닐기, 파이레닐기, 페날레닐기, 페릴레닐기, 크라이세닐기, 플루오레닐기, 플루오란테닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다. If the aryl group is a polycyclic aryl group, the number of carbon atoms is not particularly limited. It is preferable to have 10 to 60 carbon atoms. Specifically, polycyclic aryl groups include naphthyl group, anthryl group, phenanthryl group, triphenylenyl group, pyrenyl group, phenalenyl group, perylenyl group, chrysenyl group, fluorenyl group, and fluoranthenyl group. However, it is not limited to this.
본 명세서에 있어서, 상기 플루오레닐기는 치환될 수 있으며, 인접한 기들이 서로 결합하여 고리를 형성할 수 있다. In the present specification, the fluorenyl group may be substituted, and adjacent groups may combine with each other to form a ring.
상기 플루오레닐기가 치환되는 경우, , , 및 등이 될 수 있다. 다만, 이에 한정되는 것은 아니다.When the fluorenyl group is substituted, , , and It can be etc. However, it is not limited to this.
상기 아릴렌기는 2가인 것을 제외하고 상술한 아릴기의 설명을 인용할 수 있다.The description of the aryl group described above may be cited except that the arylene group is divalent.
본 명세서에 있어서, 헤테로고리기는 탄소가 아닌 원자, 이종원소를 1 이상 포함하는 것으로서, 구체적으로 상기 이종원소는 O, N, S 및 P 등으로 이루어진 군에서 선택되는 원자를 1 이상 포함할 수 있다. 탄소수는 특별히 한정되지 않으나, 탄소수 1 내지 60, 나아가 2 내지 60인 것이 바람직하며, 상기 헤테로고리기는 단환식 또는 다환식일 수 있다. 상기 헤테로고리기는 방향족 고리, 지방족 고리 및 이들이 축합된 고리일 수 있다. 상기 헤테로고리기의 예로는 티오펜기, 퓨라닐기, 피롤기, 이미다졸릴기, 티아졸릴기, 옥사졸릴기, 옥사디아졸릴기, 피리딜기, 바이피리딜기, 피리미딜기, 트리아지닐기, 트리아졸릴기, 아크리딜기, 피리다지닐기, 피라지닐기, 퀴놀릴기, 퀴나졸릴기, 퀴녹살릴기, 프탈라지닐기, 피리도 피리미딜기, 피리도 피라지닐기, 피라지노 피라지닐기, 이소퀴놀릴기, 인돌릴기, 카바졸릴기, 벤즈옥사졸릴기, 벤즈이미다졸릴기, 벤조티아졸릴기, 벤조카바졸릴기, 벤조티오페닐기, 디벤조티오페닐기, 벤조퓨라닐기, 페난쓰롤리닐기(phenanthroline), 이소옥사졸릴기, 티아디아졸릴기, 페노티아지닐기 및 디벤조퓨라닐기 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the heterocyclic group includes one or more atoms other than carbon and a heterogeneous element. Specifically, the heterocyclic group may include one or more atoms selected from the group consisting of O, N, S, and P. . The number of carbon atoms is not particularly limited, but is preferably 1 to 60 carbon atoms, and more preferably 2 to 60 carbon atoms, and the heterocyclic group may be monocyclic or polycyclic. The heterocyclic group may be an aromatic ring, an aliphatic ring, or a condensed ring thereof. Examples of the heterocyclic group include thiophene group, furanyl group, pyrrole group, imidazolyl group, thiazolyl group, oxazolyl group, oxadiazolyl group, pyridyl group, bipyridyl group, pyrimidyl group, triazinyl group, Triazolyl group, acridyl group, pyridazinyl group, pyrazinyl group, quinolyl group, quinazolyl group, quinoxalyl group, phthalazinyl group, pyrido pyrimidyl group, pyrido pyrazinyl group, pyrazino pyrazinyl group, isoquinolyl group, indolyl group, carbazolyl group, benzoxazolyl group, benzimidazolyl group, benzothiazolyl group, benzocarbazolyl group, benzothiophenyl group, dibenzothiophenyl group, benzofuranyl group, phenanth These include, but are not limited to, phenanthroline, isoxazolyl, thiadiazolyl, phenothiazinyl, and dibenzofuranyl.
상기 헤테로아릴기는 1가의 방향족 헤테로고리기를 의미하며, 헤테로아릴렌기는 2가의 방향족 헤테로고리기를 의미한다. 상기 헤테로아릴기 및 헤테로아릴렌기는 방향족인 점을 제외하고, 상술한 헤테로고리기의 설명을 인용할 수 있다. The heteroaryl group refers to a monovalent aromatic heterocyclic group, and the heteroarylene group refers to a divalent aromatic heterocyclic group. The description of the heterocyclic group described above may be cited, except that the heteroaryl group and heteroarylene group are aromatic.
본 명세서에 있어서, "에너지 준위"는 에너지의 크기를 의미하는 것이다. 따라서, 진공준위로부터 마이너스(-) 방향으로 에너지 준위가 표시되는 경우에도, 에너지 준위는 해당 에너지 값의 절대값을 의미하는 것으로 해석된다. 예컨대, HOMO(highest occupied molecular orbital) 에너지 준위란 진공준위로부터 최고 점유 분자 오비탈까지의 거리를 의미한다. 또한, LUMO(lowest unoccupied molecular orbital) 에너지 준위란 진공준위로부터 최저 비점유 분자 오비탈까지의 거리를 의미한다. In this specification, “energy level” means the amount of energy. Therefore, even when the energy level is displayed in the minus (-) direction from the vacuum level, the energy level is interpreted to mean the absolute value of the corresponding energy value. For example, the highest occupied molecular orbital (HOMO) energy level refers to the distance from the vacuum level to the highest occupied molecular orbital. Additionally, the lowest unoccupied molecular orbital (LUMO) energy level refers to the distance from the vacuum level to the lowest unoccupied molecular orbital.
본 명세서의 일 실시상태에 따르면, 상기 화학식 1의 *는 하기 화학식 2와 결합한다. 구체적으로, 상기 화학식 1에서 2개의 *는 하기 화학식 2에서 2개의 *와 결합되며, 결합방향은 한정되지 않는다.According to an exemplary embodiment of the present specification, * in Formula 1 is combined with Formula 2 below. Specifically, two * in Formula 1 are bonded to two * in Formula 2 below, and the bonding direction is not limited.
[화학식 2][Formula 2]
상기 화학식 2에 있어서,In Formula 2,
X는 O, S, NR, 또는 CR'R"이고,X is O, S, NR, or CR'R",
R, R', R" 및 R3는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이며,R, R', R" and R3 are the same or different from each other and are each independently hydrogen; deuterium; substituted or unsubstituted alkyl group; or substituted or unsubstituted aryl group,
c는 0 내지 4의 정수이고,c is an integer from 0 to 4,
c가 2 이상일 경우, 2 이상의 R3는 서로 같거나 상이하며,When c is 2 or more, 2 or more R3s are the same or different from each other,
*는 상기 화학식 1과 결합되는 위치이다.* is the position bonded to Formula 1 above.
본 명세서의 일 실시상태에 있어서, 상기 화학식 1은 하기 화학식 1-1 또는 1-2로 표시된다.In an exemplary embodiment of the present specification, Formula 1 is represented by the following Formula 1-1 or 1-2.
[화학식 1-1][Formula 1-1]
[화학식 1-2][Formula 1-2]
상기 화학식 1-1 및 1-2에 있어서,In Formulas 1-1 and 1-2,
L1, L2, R1 내지 R3, Az1, Az2, Ar2, X 및 a 내지 c의 정의는 화학식 1 및 2에서와 같다.The definitions of L1, L2, R1 to R3, Az1, Az2, Ar2, X and a to c are the same as in Formulas 1 and 2.
본 명세서의 일 실시상태에 있어서, 상기 화학식 1은 하기 화학식 2-1 내지 2-12 중 어느 하나로 표시된다.In an exemplary embodiment of the present specification, Formula 1 is represented by any one of the following Formulas 2-1 to 2-12.
[화학식 2-1][Formula 2-1]
[화학식 2-2][Formula 2-2]
[화학식 2-3][Formula 2-3]
[화학식 2-4][Formula 2-4]
[화학식 2-5][Formula 2-5]
[화학식 2-6][Formula 2-6]
[화학식 2-7][Formula 2-7]
[화학식 2-8][Formula 2-8]
[화학식 2-9][Formula 2-9]
[화학식 2-10][Formula 2-10]
[화학식 2-11][Formula 2-11]
[화학식 2-12][Formula 2-12]
상기 화학식 2-1 내지 2-12에 있어서,In Formulas 2-1 to 2-12,
L1, L2, R1 내지 R3, Az1, Az2, Ar2, X 및 a 내지 c의 정의는 화학식 1 및 2에서와 같다.The definitions of L1, L2, R1 to R3, Az1, Az2, Ar2, X and a to c are the same as in Formulas 1 and 2.
본 명세서의 일 실시상태에 있어서, 상기 Az1 및 Az2 중 어느 하나는 -L10-Ar1이며, 나머지 하나는 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.In an exemplary embodiment of the present specification, one of Az1 and Az2 is -L10-Ar1, and the other is hydrogen; heavy hydrogen; Substituted or unsubstituted alkyl group; Or it is a substituted or unsubstituted aryl group.
또 하나의 일 실시상태에 따르면, 상기 Az1 및 Az2 중 어느 하나는 -L10-Ar1이며, 나머지 하나는 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이다.According to another embodiment, one of Az1 and Az2 is -L10-Ar1, and the other is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; Or it is a substituted or unsubstituted aryl group having 6 to 60 carbon atoms.
또 하나의 일 실시상태에 있어서, 상기 Az1은 -L10-Ar1이다.In another embodiment, Az1 is -L10-Ar1.
또 하나의 일 실시상태에 따르면, 상기 Az1은 -L10-Ar1이고, Az2는 수소 또는 중수소이다.According to another embodiment, Az1 is -L10-Ar1, and Az2 is hydrogen or deuterium.
또 하나의 일 실시상태에 있어서, 상기 Az2는 -L10-Ar1이고, Az1은 수소 또는 중수소이다.In another embodiment, Az2 is -L10-Ar1, and Az1 is hydrogen or deuterium.
본 명세서의 일 실시상태에 따르면, 상기 Ar1은 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이다.According to an exemplary embodiment of the present specification, Ar1 is a substituted or unsubstituted aryl group having 6 to 60 carbon atoms.
또 하나의 일 실시상태에 있어서, 상기 Ar1은 중수소로 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이다.In another embodiment, Ar1 is an aryl group having 6 to 60 carbon atoms that is unsubstituted or substituted with deuterium.
또 하나의 일 실시상태에 따르면, 상기 Ar1은 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.According to another exemplary embodiment, Ar1 is a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
또 하나의 일 실시상태에 있어서, 상기 Ar1은 중수소로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In another embodiment, Ar1 is an aryl group having 6 to 30 carbon atoms that is unsubstituted or substituted with deuterium.
또 하나의 일 실시상태에 따르면, 상기 Ar1은 치환 또는 비치환된 페닐기; 치환 또는 비치환된 비페닐기; 치환 또는 비치환된 나프틸기; 또는 치환 또는 비치환된 페난트릴기이다.According to another exemplary embodiment, Ar1 is a substituted or unsubstituted phenyl group; Substituted or unsubstituted biphenyl group; Substituted or unsubstituted naphthyl group; Or a substituted or unsubstituted phenanthryl group.
또 하나의 일 실시상태에 있어서, 상기 Ar1은 중수소로 치환 또는 비치환된 페닐기; 중수소로 치환 또는 비치환된 비페닐기; 중수소로 치환 또는 비치환된 나프틸기; 또는 중수소로 치환 또는 비치환된 페난트릴기이다.In another exemplary embodiment, Ar1 is a phenyl group unsubstituted or substituted with deuterium; Biphenyl group substituted or unsubstituted with deuterium; Naphthyl group substituted or unsubstituted with deuterium; Or it is a phenanthryl group substituted or unsubstituted with deuterium.
본 명세서의 일 실시상태에 있어서, 상기 L10은 직접결합; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴렌기이다.In one embodiment of the present specification, L10 is a direct bond; Or it is a substituted or unsubstituted arylene group having 6 to 60 carbon atoms.
또 하나의 일 실시상태에 따르면, 상기 L10은 직접결합; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 60의 아릴렌기이다.According to another embodiment, L10 is a direct bond; Or, it is an arylene group having 6 to 60 carbon atoms substituted or unsubstituted with deuterium.
또 하나의 일 실시상태에 따르면, 상기 L10은 직접결합; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴렌기이다.According to another embodiment, L10 is a direct bond; Or it is a substituted or unsubstituted arylene group having 6 to 30 carbon atoms.
또 하나의 일 실시상태에 따르면, 상기 L10은 직접결합; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 30의 아릴렌기이다.According to another embodiment, L10 is a direct bond; Or, it is an arylene group having 6 to 30 carbon atoms substituted or unsubstituted with deuterium.
또 하나의 일 실시상태에 따르면, 상기 L10은 직접결합; 치환 또는 비치환된 페닐렌기; 또는 치환 또는 비치환된 나프틸렌기이다.According to another embodiment, L10 is a direct bond; Substituted or unsubstituted phenylene group; Or a substituted or unsubstituted naphthylene group.
또 하나의 일 실시상태에 따르면, 상기 L10은 직접결합; 중수소로 치환 또는 비치환된 페닐렌기; 또는 중수소로 치환 또는 비치환된 나프틸렌기이다.According to another embodiment, L10 is a direct bond; A phenylene group substituted or unsubstituted with deuterium; Or it is a naphthylene group substituted or unsubstituted with deuterium.
본 명세서의 일 실시상태에 따르면, 상기 L1 및 L2는 서로 같거나 상이하고, 각각 독립적으로 직접결합; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴렌기이다.According to an exemplary embodiment of the present specification, L1 and L2 are the same or different from each other and are each independently directly bonded; Or it is a substituted or unsubstituted arylene group having 6 to 60 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 L1 및 L2는 서로 같거나 상이하고, 각각 독립적으로 직접결합; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 60의 아릴렌기이다.In an exemplary embodiment of the present specification, L1 and L2 are the same or different from each other and are each independently directly bonded; Or, it is an arylene group having 6 to 60 carbon atoms substituted or unsubstituted with deuterium.
본 명세서의 일 실시상태에 따르면, 상기 L1 및 L2는 서로 같거나 상이하고, 각각 독립적으로 직접결합; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴렌기이다.According to an exemplary embodiment of the present specification, L1 and L2 are the same or different from each other and are each independently directly bonded; Or it is a substituted or unsubstituted arylene group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 L1 및 L2는 서로 같거나 상이하고, 각각 독립적으로 직접결합; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 30의 아릴렌기이다.In an exemplary embodiment of the present specification, L1 and L2 are the same or different from each other and are each independently directly bonded; Or, it is an arylene group having 6 to 30 carbon atoms substituted or unsubstituted with deuterium.
또 하나의 일 실시상태에 따르면, 상기 L1 및 L2는 서로 같거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 페닐렌기; 또는 치환 또는 비치환된 나프틸렌기이다.According to another embodiment, L1 and L2 are the same or different from each other and are each independently directly bonded; Substituted or unsubstituted phenylene group; Or a substituted or unsubstituted naphthylene group.
또 하나의 일 실시상태에 있어서, 상기 L1 및 L2는 서로 같거나 상이하고, 각각 독립적으로 직접결합; 중수소로 치환 또는 비치환된 페닐렌기; 또는 중수소로 치환 또는 비치환된 나프틸렌기이다.In another embodiment, L1 and L2 are the same or different from each other and are each independently directly bonded; A phenylene group substituted or unsubstituted with deuterium; Or it is a naphthylene group substituted or unsubstituted with deuterium.
본 명세서의 일 실시상태에 따르면, 상기 R1 및 R2는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이다.According to an exemplary embodiment of the present specification, R1 and R2 are the same as or different from each other, and are each independently hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; Or it is a substituted or unsubstituted aryl group having 6 to 60 carbon atoms.
또 하나의 일 실시상태에 있어서, 상기 R1 및 R2는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 중수소로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이다.In another exemplary embodiment, R1 and R2 are the same as or different from each other, and are each independently hydrogen; heavy hydrogen; An alkyl group having 1 to 30 carbon atoms substituted or unsubstituted with deuterium; Or, it is an aryl group having 6 to 60 carbon atoms that is unsubstituted or substituted with deuterium.
또 하나의 일 실시상태에 따르면, 상기 R1 및 R2는 서로 같거나 상이하고, 각각 독립적으로 수소 또는 중수소이다.According to another exemplary embodiment, R1 and R2 are the same or different from each other and are each independently hydrogen or deuterium.
본 명세서의 일 실시상태에 따르면, 상기 a는 0 내지 5의 정수이고, a가 2 이상일 경우, 2 이상의 R1은 서로 같거나 상이하다.According to an exemplary embodiment of the present specification, a is an integer from 0 to 5, and when a is 2 or more, 2 or more R1 are the same or different from each other.
본 명세서의 일 실시상태에 따르면, 상기 b는 0 내지 6의 정수이고, b가 2 이상일 경우, 2 이상의 R2는 서로 같거나 상이하다.According to an exemplary embodiment of the present specification, b is an integer from 0 to 6, and when b is 2 or more, 2 or more R2s are the same or different from each other.
본 명세서의 일 실시상태에 있어서, 상기 화학식 2의 X는 O, S, NR, 또는 CR'R"이다.In an exemplary embodiment of the present specification, X in Formula 2 is O, S, NR, or CR'R".
또 하나의 일 실시상태에 따르면, 상기 X는 O이다.According to another exemplary embodiment, X is O.
또 하나의 일 실시상태에 따르면, 상기 X는 S이다.According to another exemplary embodiment, X is S.
또 하나의 일 실시상태에 따르면, 상기 X는 NR이다.According to another exemplary embodiment, X is NR.
또 하나의 일 실시상태에 따르면, 상기 X는 CR'R"이다.According to another embodiment, X is CR'R".
본 명세서의 일 실시상태에 따르면, 상기 화학식 2의 R, R', R" 및 R3는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이다.According to an exemplary embodiment of the present specification, R, R', R", and R3 in Formula 2 are the same or different from each other, and are each independently hydrogen; deuterium; substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; or substituted Or it is an unsubstituted aryl group having 6 to 60 carbon atoms.
또 하나의 일 실시상태에 따르면, 상기 R, R', R" 및 R3는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 중수소로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이다.According to another embodiment, R, R', R", and R3 are the same as or different from each other, and each independently represents hydrogen; deuterium; an alkyl group of 1 to 30 carbon atoms substituted or unsubstituted with deuterium; or deuterium. It is a substituted or unsubstituted aryl group having 6 to 60 carbon atoms.
본 명세서의 일 실시상태에 따르면, 상기 R은 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.According to an exemplary embodiment of the present specification, R is a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
또 하나의 일 실시상태에 따르면, 상기 R은 치환 또는 비치환된 페닐기이다.According to another exemplary embodiment, R is a substituted or unsubstituted phenyl group.
또 하나의 일 실시상태에 있어서, 상기 R은 페닐기이다.In another exemplary embodiment, R is a phenyl group.
본 명세서의 일 실시상태에 따르면, 상기 R' 및 R"는 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.According to an exemplary embodiment of the present specification, R' and R" are the same as or different from each other, and are each independently a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms am.
또 하나의 일 실시상태에 따르면, 상기 R' 및 R"는 서로 같거나 상이하고, 각각 독립적으로 메틸기 또는 페닐기이다.According to another embodiment, R' and R" are the same or different from each other, and are each independently a methyl group or a phenyl group.
또 하나의 일 실시상태에 있어서, 상기 R' 및 R"는 메틸기이다.In another exemplary embodiment, R' and R" are methyl groups.
또 하나의 일 실시상태에 따르면, 상기 R' 및 R"는 페닐기이다.According to another exemplary embodiment, R' and R" are phenyl groups.
본 명세서의 일 실시상태에 있어서, 상기 R3는 수소 또는 중수소이다.In one embodiment of the present specification, R3 is hydrogen or deuterium.
본 명세서의 일 실시상태에 따르면, 화학식 2의 c는 0 내지 4의 정수이고, c가 2 이상일 경우, 2 이상의 R3는 서로 같거나 상이하다.According to an exemplary embodiment of the present specification, c in Formula 2 is an integer of 0 to 4, and when c is 2 or more, 2 or more R3 are the same or different from each other.
본 명세서의 일 실시상태에 있어서, 상기 Ar2는 치환 또는 비치환된 탄소수 6 내지 60의 아릴기; 또는 치환 또는 비치환된 이종원소로 O를 1 이상 포함하는 탄소수 2 내지 60의 헤테로고리이다.In one embodiment of the present specification, Ar2 is a substituted or unsubstituted aryl group having 6 to 60 carbon atoms; Or, it is a substituted or unsubstituted heteroelement and is a heterocycle having 2 to 60 carbon atoms containing at least 1 O.
또 하나의 일 실시상태에 따르면, 상기 Ar2는 중수소로 치환 또는 비치환된 탄소수 6 내지 60의 아릴기; 또는 중수소로 치환 또는 비치환된 이종원소로 O를 1 이상 포함하는 탄소수 2 내지 60의 헤테로고리이다.According to another embodiment, Ar2 is an aryl group having 6 to 60 carbon atoms that is unsubstituted or substituted with deuterium; Or, it is a heterocycle substituted or unsubstituted with deuterium and has 2 to 60 carbon atoms and contains at least 1 O.
또 하나의 일 실시상태에 따르면, 상기 Ar2는 치환 또는 비치환된 페닐기; 치환 또는 비치환된 비페닐기; 치환 또는 비치환된 나프틸기; 치환 또는 비치환된 페난트릴기; 치환 또는 비치환된 트리페닐레닐기; 치환 또는 비치환된 파이레닐기; 치환 또는 비치환된 플루오레닐기; 치환 또는 비치환된 디벤조퓨라닐기; 치환 또는 비치환된 디벤조티오페닐기; 치환 또는 비치환된 카바졸릴기; 또는 치환 또는 비치환된 하기 화학식 1-A이다.According to another exemplary embodiment, Ar2 is a substituted or unsubstituted phenyl group; Substituted or unsubstituted biphenyl group; Substituted or unsubstituted naphthyl group; Substituted or unsubstituted phenanthryl group; Substituted or unsubstituted triphenylenyl group; Substituted or unsubstituted pyrenyl group; Substituted or unsubstituted fluorenyl group; Substituted or unsubstituted dibenzofuranyl group; Substituted or unsubstituted dibenzothiophenyl group; Substituted or unsubstituted carbazolyl group; or substituted or unsubstituted formula 1-A.
[화학식 1-A][Formula 1-A]
상기 화학식 1-A에 있어서,In Formula 1-A,
Y는 O, S, NRa, 또는 CRbRc이고,Y is O, S, NRa, or CRbRc,
Ra, Rb 및 Rc는 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이며,Ra, Rb and Rc are the same or different from each other and are each independently a substituted or unsubstituted alkyl group; Substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
는 L2에 결합되는 위치를 의미한다. means the position bound to L2.
또 하나의 일 실시상태에 따르면, 상기 Ar2는 중수소로 치환 또는 비치환된 페닐기; 중수소로 치환 또는 비치환된 비페닐기; 중수소로 치환 또는 비치환된 나프틸기; 중수소로 치환 또는 비치환된 페난트릴기; 중수소로 치환 또는 비치환된 트리페닐레닐기; 중수소로 치환 또는 비치환된 파이레닐기; 중수소, 알킬기 및 아릴기로 이루어진 군으로부터 선택된 1 이상의 치환기로 치환 또는 비치환된 플루오레닐기; 중수소로 치환 또는 비치환된 디벤조퓨라닐기; 중수소로 치환 또는 비치환된 디벤조티오페닐기; 중수소 및 아릴기로 이루어진 군으로부터 선택된 1 이상의 치환기로 치환 또는 비치환된 카바졸릴기; 또는 중수소로 치환 또는 비치환된 하기 화학식 1-A이다.According to another embodiment, Ar2 is a phenyl group unsubstituted or substituted with deuterium; Biphenyl group substituted or unsubstituted with deuterium; Naphthyl group substituted or unsubstituted with deuterium; A phenanthryl group substituted or unsubstituted with deuterium; Triphenylenyl group substituted or unsubstituted with deuterium; Pyrenyl group substituted or unsubstituted with deuterium; A fluorenyl group unsubstituted or substituted with one or more substituents selected from the group consisting of deuterium, alkyl group, and aryl group; Dibenzofuranyl group substituted or unsubstituted with deuterium; Dibenzothiophenyl group substituted or unsubstituted with deuterium; A carbazolyl group substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and aryl groups; Or it is the formula 1-A below, substituted or unsubstituted with deuterium.
[화학식 1-A][Formula 1-A]
상기 화학식 1-A에 있어서,In Formula 1-A,
Y는 O, S, NRa, 또는 CRbRc이고,Y is O, S, NRa, or CRbRc,
Ra, Rb 및 Rc는 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이며,Ra, Rb and Rc are the same or different from each other and are each independently a substituted or unsubstituted alkyl group; Substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
는 L2에 결합되는 위치를 의미한다. means the position bound to L2.
본 명세서의 일 실시상태에 있어서, 상기 화학식 1-A의 치환기 정의에서 "치환 또는 비치환된"은 중수소; 탄소수 1 내지 20의 알킬기; 탄소수 6 내지 30의 아릴기; 및 탄소수 2 내지 30의 헤테로고리기로 이루어진 군으로부터 선택된 1 이상의 치환기로 치환 또는 비치환되는 것을 의미한다.In an exemplary embodiment of the present specification, in the definition of a substituent in Formula 1-A, “substituted or unsubstituted” refers to deuterium; an alkyl group having 1 to 20 carbon atoms; Aryl group having 6 to 30 carbon atoms; and substituted or unsubstituted with one or more substituents selected from the group consisting of heterocyclic groups having 2 to 30 carbon atoms.
본 명세서의 일 실시상태에 따르면, 상기 Ra, Rb 및 Rc는 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 치환 또는 비치환된 탄소수 6 내지 60의 아릴기; 또는 치환 또는 비치환된 탄소수 2 내지 60의 헤테로고리기이다.According to an exemplary embodiment of the present specification, Ra, Rb, and Rc are the same as or different from each other, and are each independently a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; A substituted or unsubstituted aryl group having 6 to 60 carbon atoms; Or it is a substituted or unsubstituted heterocyclic group having 2 to 60 carbon atoms.
또 하나의 일 실시상태에 따르면, 상기 Ra, Rb 및 Rc는 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 20의 알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 또는 치환 또는 비치환된 탄소수 2 내지 30의 헤테로고리기이다.According to another embodiment, Ra, Rb, and Rc are the same or different from each other, and are each independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; Or it is a substituted or unsubstituted heterocyclic group having 2 to 30 carbon atoms.
본 명세서의 일 실시상태에 따르면, 상기 Ra는 치환 또는 비치환된 페닐기이다.According to an exemplary embodiment of the present specification, Ra is a substituted or unsubstituted phenyl group.
본 명세서의 일 실시상태에 따르면, 상기 Rb 및 Rc는 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 메틸기; 또는 치환 또는 비치환된 페닐기이다.According to an exemplary embodiment of the present specification, Rb and Rc are the same as or different from each other, and each independently represents a substituted or unsubstituted methyl group; Or a substituted or unsubstituted phenyl group.
본 명세서의 일 실시상태에 따르면, 상기 화학식 1에서 안트라센, Ar1, Ar2 및 화학식 2가 축합된 디벤조퓨란은 각각 1 이상의 중수소를 포함한다.According to an exemplary embodiment of the present specification, the dibenzofuran in which anthracene, Ar1, Ar2, and Formula 2 in Formula 1 are condensed each contain one or more deuterium.
본 명세서의 일 실시상태에 따르면, 상기 화학식 1에서 안트라센, Ar2 및 화학식 2가 축합된 디벤조퓨란은 각각 1 이상의 중수소를 포함한다.According to an exemplary embodiment of the present specification, the dibenzofuran in which anthracene, Ar2, and Formula 2 in Formula 1 are condensed each contain one or more deuterium.
본 명세서의 일 실시상태에 따르면, 상기 화학식 1에서 안트라센, Ar1 및 Ar2은 각각 1 이상의 중수소를 포함한다.According to an exemplary embodiment of the present specification, in Formula 1, anthracene, Ar1, and Ar2 each contain one or more deuterium.
본 명세서의 일 실시상태에 따르면, 상기 화학식 1에서 Ar2는 1 이상의 중수소를 포함한다.According to an exemplary embodiment of the present specification, in Formula 1, Ar2 includes one or more deuterium.
본 명세서의 일 실시상태에 따르면, 상기 화학식 1에서 화학식 2가 축합된 디벤조퓨란은 1 이상의 중수소를 포함한다.According to an exemplary embodiment of the present specification, the dibenzofuran in which formula 2 is condensed in formula 1 includes one or more deuterium.
본 명세서의 일 실시상태에 따르면, 상기 화학식 1에서 안트라센 및 Ar1은 각각 1 이상의 중수소를 포함한다.According to an exemplary embodiment of the present specification, in Formula 1, anthracene and Ar1 each include one or more deuterium.
본 명세서의 일 실시상태에 따르면, 상기 화학식 1에서 안트라센, Ar1 및 화학식 2가 축합된 디벤조퓨란은 각각 1 이상의 중수소를 포함한다.According to an exemplary embodiment of the present specification, the dibenzofuran in which anthracene, Ar1, and Formula 2 in Formula 1 are condensed each contain one or more deuterium.
본 명세서의 일 실시상태에 따르면, 상기 화합물은 1 이상의 중수소를 포함한다. 상기 화합물이 중수소를 포함하는 경우, 소자의 수명이 개선된다. 구체적으로 탄소-수소 결합의 진동수 보다 탄소-중수소 결합의 진동수가 작아지므로 탄소-중수소 결합을 포함하는 화합물은 안정성이 개선된다.According to an exemplary embodiment of the present specification, the compound contains one or more deuterium. When the compound contains deuterium, the lifespan of the device is improved. Specifically, since the frequency of the carbon-deuterium bond becomes smaller than that of the carbon-hydrogen bond, the stability of compounds containing carbon-deuterium bonds is improved.
본 명세서의 일 실시상태에 있어서, 상기 화합물의 중수소 치환율은 10% 내지 100%이다. In one embodiment of the present specification, the deuterium substitution rate of the compound is 10% to 100%.
본 명세서에 있어서, 중수소 치환율이란 분자 내에서 중수소의 치환 비율을 의미하는 것으로서, 공지의 방법을 통하여 확인할 수 있다. 일 예로 분자 내에서 중수소의 치환 분포 파악은 하기와 같은 방법을 따른다. 하기 TLC-MS은 화합물의 합성 과정에서 중수소의 치환비율을 조절하기 위한 방법이다.In this specification, the deuterium substitution rate refers to the rate of deuterium substitution within the molecule, and can be confirmed through a known method. As an example, the distribution of deuterium substitution within a molecule can be determined using the following method. The following TLC-MS is a method for controlling the substitution ratio of deuterium during the synthesis of a compound.
1. TLC-MS (Thin-Layer Chromatography/Mass Spectrometry) 를 활용 (합성 과정 확인법)1. Utilize TLC-MS (Thin-Layer Chromatography/Mass Spectrometry) (method to confirm synthesis process)
반응의 종결시점에 분자량들이 이루는 분포의 최대값(max.값)을 기준으로 치환율을 계산할 수 있다. The substitution rate can be calculated based on the maximum value (max. value) of the distribution of molecular weights at the end of the reaction.
본 명세서의 일 실시상태에 있어서, 상기 화학식 1은 하기 화합물 중에서 선택된다.In one embodiment of the present specification, Formula 1 is selected from the following compounds.
본 명세서의 일 실시상태는 제1 전극; 상기 제1 전극과 대향하여 구비되는 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비되는 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상이 전술한 화학식 1로 표시되는 화합물을 포함하는 유기 발광 소자를 제공한다.An exemplary embodiment of the present specification includes a first electrode; a second electrode provided opposite the first electrode; and an organic light-emitting device comprising at least one organic material layer provided between the first electrode and the second electrode, wherein at least one layer of the organic material layer includes a compound represented by the above-described formula (1). .
본 명세서의 유기 발광 소자는 전술한 화합물을 이용하여 한 층 이상의 유기물층을 형성하는 것을 제외하고는, 통상의 유기 발광 소자의 제조방법 및 재료에 의하여 제조될 수 있다.The organic light emitting device of the present specification can be manufactured using conventional organic light emitting device manufacturing methods and materials, except that one or more organic material layers are formed using the above-described compounds.
본 명세서의 유기 발광 소자의 유기물층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 본 발명의 유기 발광 소자는 유기물층으로서 정공주입층, 정공수송층, 정공수송 및 정공주입을 동시에 하는 층, 전자억제층, 발광층, 전자수송층, 전자주입층, 전자수송 및 전자주입을 동시에 하는 층 등을 포함하는 구조를 가질 수 있다. 그러나, 유기 발광 소자의 구조는 이에 한정되지 않고 더 적은 수 또는 더 많은 수의 유기물층을 포함할 수 있다.The organic material layer of the organic light emitting device of the present specification may have a single-layer structure, or may have a multi-layer structure in which two or more organic material layers are stacked. For example, the organic light-emitting device of the present invention includes an organic material layer that includes a hole injection layer, a hole transport layer, a layer that simultaneously performs hole transport and hole injection, an electron suppressing layer, a light-emitting layer, an electron transport layer, an electron injection layer, and a layer that performs both electron transport and electron injection. It may have a structure including etc. However, the structure of the organic light emitting device is not limited to this and may include fewer or more organic material layers.
본 명세서의 일 실시상태에 있어서, 상기 유기물층은 정공주입층 또는 정공수송층을 포함하고, 상기 정공주입층 또는 정공수송층은 상기 화합물을 포함한다. In one embodiment of the present specification, the organic material layer includes a hole injection layer or a hole transport layer, and the hole injection layer or hole transport layer includes the compound.
본 명세서의 일 실시상태에 있어서, 상기 유기물층은 전자수송층 또는 전자주입층을 포함하고, 상기 전자수송층 또는 전자주입층은 상기 화합물을 포함한다.In one embodiment of the present specification, the organic material layer includes an electron transport layer or an electron injection layer, and the electron transport layer or electron injection layer includes the compound.
본 명세서의 일 실시상태에 있어서, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 상기 화합물을 포함한다. In one embodiment of the present specification, the organic material layer includes a light-emitting layer, and the light-emitting layer includes the compound.
본 명세서의 일 실시상태에 있어서, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 상기 화합물을 발광층의 호스트로 포함한다.In one embodiment of the present specification, the organic material layer includes a light-emitting layer, and the light-emitting layer includes the compound as a host of the light-emitting layer.
본 명세서의 일 실시상태에 있어서, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 전술한 화합물을 발광층의 호스트로서 포함하고, 도펀트를 더 포함할 수 있다.In one embodiment of the present specification, the organic material layer includes a light-emitting layer, and the light-emitting layer includes the above-described compound as a host of the light-emitting layer, and may further include a dopant.
본 명세서의 일 실시상태에 있어서, 상기 제1 전극은 양극이고, 제2 전극은 음극이다.In one embodiment of the present specification, the first electrode is an anode and the second electrode is a cathode.
또 하나의 일 실시상태에 따르면, 상기 제1 전극은 음극이고, 제2 전극은 양극이다.According to another exemplary embodiment, the first electrode is a cathode and the second electrode is an anode.
본 발명의 유기 발광 소자의 구조는 도 1 내지 3에 나타낸 것과 같은 구조를 가질 수 있으나, 이에만 한정되는 것은 아니다.The structure of the organic light emitting device of the present invention may have the same structure as shown in FIGS. 1 to 3, but is not limited thereto.
도 1에는 기판(1) 위에 양극(2), 발광층(3) 및 음극(4)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화합물은 상기 발광층(3)에 포함될 수 있다.Figure 1 illustrates the structure of an organic light-emitting device in which an anode 2, a light-emitting layer 3, and a cathode 4 are sequentially stacked on a substrate 1. In this structure, the compound may be included in the light-emitting layer 3.
도 2에는 기판(1) 위에 양극(2), 정공주입층(5), 정공수송층(6), 발광층(7), 전자수송층(8) 및 음극(4)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화합물은 상기 정공주입층(5), 정공수송층(6), 발광층(7) 또는 전자수송층(8)에 포함될 수 있다.Figure 2 shows an organic light emitting device in which an anode (2), a hole injection layer (5), a hole transport layer (6), a light emitting layer (7), an electron transport layer (8), and a cathode (4) are sequentially stacked on a substrate (1). The structure is illustrated. In this structure, the compound may be included in the hole injection layer (5), the hole transport layer (6), the light emitting layer (7), or the electron transport layer (8).
도 3에는 기판(1) 위에 양극(2), 정공주입층(5), 정공수송층(6), 발광층(7), 전자수송층(8), 전자주입층(9) 및 음극(4)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화합물은 상기 정공주입층(5), 정공수송층(6), 발광층(7) 또는 전자수송층(8)에 포함될 수 있다.In Figure 3, the anode (2), hole injection layer (5), hole transport layer (6), light emitting layer (7), electron transport layer (8), electron injection layer (9), and cathode (4) are sequentially placed on the substrate (1). The structure of a stacked organic light emitting device is illustrated. In this structure, the compound may be included in the hole injection layer (5), the hole transport layer (6), the light emitting layer (7), or the electron transport layer (8).
예컨대, 본 명세서의 유기 발광 소자는 스퍼터링(sputtering)이나 전자빔 증발(e-beam evaporation)과 같은 PVD(physical vapor deposition) 방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공주입층, 정공수송층, 발광층, 전자억제층, 전자수송층 및 전자주입층을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다. 이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 만들 수도 있다.For example, the organic light emitting device of the present specification uses a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation to deposit a metal, a conductive metal oxide, or an alloy thereof on a substrate. It can be manufactured by forming an anode by vapor deposition, forming an organic material layer including a hole injection layer, a hole transport layer, a light-emitting layer, an electron suppression layer, an electron transport layer, and an electron injection layer thereon, and then depositing a material that can be used as a cathode on it. You can. In addition to this method, an organic light-emitting device can also be made by sequentially depositing a cathode material, an organic material layer, and an anode material on a substrate.
상기 유기물층은 정공주입층, 정공수송층, 전자주입 및 전자수송을 동시에 하는 층, 전자억제층, 발광층, 전자수송층, 전자주입층, 전자주입 및 전자수송을 동시에 하는 층 등을 포함하는 다층 구조일 수도 있으나, 이에 한정되지 않고 단층 구조일 수 있다. 또한, 상기 유기물층은 다양한 고분자 소재를 사용하여 증착법이 아닌 용매 공정(solvent process), 예컨대 스핀 코팅, 딥 코팅, 닥터 블레이딩, 스크린 프린팅, 잉크젯 프린팅 또는 열 전사법 등의 방법에 의하여 더 적은 수의 층으로 제조할 수 있다.The organic material layer may have a multi-layer structure including a hole injection layer, a hole transport layer, a layer that simultaneously performs electron injection and electron transport, an electron suppressing layer, a light emitting layer, an electron transport layer, an electron injection layer, and a layer that simultaneously performs electron injection and electron transport. However, it is not limited to this and may have a single-layer structure. In addition, the organic material layer uses a variety of polymer materials to form a smaller number of layers by using a solvent process rather than a deposition method, such as spin coating, dip coating, doctor blading, screen printing, inkjet printing, or thermal transfer. It can be manufactured in layers.
상기 양극은 정공을 주입하는 전극으로, 양극 물질로는 통상 유기물층으로 정공 주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 본 발명에서 사용될 수 있는 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연 산화물, 인듐 산화물, 인듐주석 산화물(ITO, Indium Tin Oxide), 인듐아연 산화물(IZO, Indium Zinc Oxide)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDOT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.The anode is an electrode that injects holes, and the anode material is generally preferably a material with a large work function to facilitate hole injection into the organic layer. Specific examples of anode materials that can be used in the present invention include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO:Al or SnO 2 :Sb; Conductive polymers such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene](PEDOT), polypyrrole, and polyaniline are included, but are not limited to these.
상기 음극은 전자를 주입하는 전극으로, 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 티타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다.The cathode is an electrode that injects electrons, and the cathode material is preferably a material with a low work function to facilitate electron injection into the organic layer. Specific examples of cathode materials include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead, or alloys thereof; There are, but are not limited to, multi-layered materials such as LiF/Al or LiO 2 /Al.
상기 정공주입층은 양극으로부터 발광층으로 정공의 주입을 원활하게 하는 역할을 하는 층이며, 정공 주입 물질로는 낮은 전압에서 양극으로부터 정공을 잘 주입 받을 수 있는 물질로서, 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrine), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴헥사아자트리페닐렌 계열의 유기물, 퀴나크리돈(quinacridone) 계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.The hole injection layer is a layer that serves to facilitate the injection of holes from the anode to the light emitting layer, and the hole injection material is a material that can well inject holes from the anode at a low voltage. HOMO (highest occupied) of the hole injection material It is preferable that the molecular orbital is between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of hole injection materials include metal porphyrine, oligothiophene, arylamine-based organic substances, hexanitrilehexaazatriphenylene-based organic substances, quinacridone-based organic substances, and perylene-based organic substances. organic substances, anthraquinone, polyaniline, and polythiophene series conductive polymers, etc., but are not limited to these.
상기 정공수송층은 정공의 수송을 원활하게 하는 역할을 할 수 있다. 정공 수송 물질로는 양극이나 정공주입층으로부터 정공을 수송받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다. The hole transport layer may play a role in facilitating the transport of holes. The hole transport material is a material that can transport holes from the anode or hole injection layer and transfer them to the light emitting layer, and a material with high mobility for holes is suitable. Specific examples include arylamine-based organic materials, conductive polymers, and block copolymers with both conjugated and non-conjugated portions, but are not limited to these.
상기 정공수송층과 발광층 사이에 전자억제층이 구비될 수 있다. 상기 전자억제층은 전술한 화합물 또는 당 기술분야에 알려져 있는 재료가 사용될 수 있다.An electron blocking layer may be provided between the hole transport layer and the light emitting layer. The electron blocking layer may be made of the above-mentioned compounds or materials known in the art.
상기 발광층은 적색, 녹색 또는 청색을 발광할 수 있으며, 인광 물질 또는 형광 물질로 이루어질 수 있다. 상기 발광 물질로는 정공수송층과 전자수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자 효율이 좋은 물질이 바람직하다. 구체적인 예로는 8-히드록시-퀴놀린 알루미늄 착물(Alq3); 카르바졸 계열 화합물; 이량체화 스티릴(dimerized styryl) 화합물; BAlq; 10-히드록시벤조 퀴놀린-금속 화합물; 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물; 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자; 스피로(spiro) 화합물; 폴리플루오렌; 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다.The light-emitting layer may emit red, green, or blue light and may be made of a phosphorescent material or a fluorescent material. The light-emitting material is a material that can emit light in the visible range by receiving and combining holes and electrons from the hole transport layer and the electron transport layer, respectively, and is preferably a material with good quantum efficiency for fluorescence or phosphorescence. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ); Carbazole-based compounds; dimerized styryl compounds; BAlq; 10-hydroxybenzoquinoline-metal compound; Compounds of the benzoxazole, benzthiazole and benzimidazole series; Poly(p-phenylenevinylene) (PPV) series polymer; Spiro compounds; polyfluorene; Rubrene, etc., but is not limited to these.
본 명세서의 일 실시상태에 있어서, 상기 발광층은 상기 화합물을 호스트로 포함하고, 상기 화합물 외에 추가의 호스트를 포함할 수 있다.In one embodiment of the present specification, the light-emitting layer includes the compound as a host and may include an additional host in addition to the compound.
상기 추가의 호스트 재료로는 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등이 있다. 구체적으로 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 카바졸 유도체, 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 등이 있으나, 이에 한정되지 않는다.The additional host materials include condensed aromatic ring derivatives or heterocycle-containing compounds. Specifically, condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, and fluoranthene compounds, and heterocycle-containing compounds include carbazole derivatives, dibenzofuran derivatives, and ladder-type compounds. These include, but are not limited to, furan compounds and pyrimidine derivatives.
상기 발광 도펀트로는 PIQIr(acac)(bis(1-phenylisoquinoline)acetylacetonateiridium), PQIr(acac)(bis(1-phenylquinoline)acetylacetonate iridium), PQIr(tris(1-phenylquinoline)iridium), PtOEP(octaethylporphyrin platinum)와 같은 인광 물질이나, Alq3(tris(8-hydroxyquinolino)aluminum)와 같은 형광 물질이 사용될 수 있으나, 이에만 한정된 것은 아니다. 발광층이 녹색 발광을 하는 경우, 발광 도펀트로는 Ir(ppy)3(fac tris(2-phenylpyridine)iridium)와 같은 인광물질이나, Alq3(tris(8-hydroxyquinolino)aluminum)와 같은 형광 물질이 사용될 수 있으나, 이에만 한정된 것은 아니다. 발광층이 청색 발광을 하는 경우, 발광 도펀트로는 (4,6-F2ppy)2Irpic와 같은 인광 물질이나, spiro-DPVBi, spiro-6P, 디스틸벤젠(DSB), 디스트릴아릴렌(DSA), PFO계 고분자, PPV계 고분자와 같은 형광 물질이 사용될 수 있으나, 이에만 한정된 것은 아니다.The light-emitting dopants include PIQIr(acac)(bis(1-phenylsoquinoline)acetylacetonate iridium), PQIr(acac)(bis(1-phenylquinoline)acetylacetonate iridium), PQIr(tris(1-phenylquinoline)iridium), and PtOEP(octaethylporphyrin platinum). A phosphorescent material such as or a fluorescent material such as Alq 3 (tris(8-hydroxyquinolino)aluminum) may be used, but is not limited thereto. If the light-emitting layer emits green light, a phosphor such as Ir(ppy) 3 (fac tris(2-phenylpyridine)iridium) or a fluorescent material such as Alq3 (tris(8-hydroxyquinolino)aluminum) can be used as the light-emitting dopant. However, it is not limited to this. If the light-emitting layer emits blue light, the light-emitting dopant may be a phosphorescent material such as (4,6-F 2 ppy) 2 Irpic, spiro-DPVBi, spiro-6P, distylbenzene (DSB), or distrylarylene (DSA). ), fluorescent materials such as PFO-based polymers and PPV-based polymers may be used, but are not limited to these.
본 명세서의 일 실시상태에 있어서, 상기 전자수송층과 발광층 사이에 정공억제층이 구비될 수 있으며, 정공억제층에는 당 기술분야에 알려져 있는 재료가 사용될 수 있다.In one embodiment of the present specification, a hole blocking layer may be provided between the electron transport layer and the light emitting layer, and materials known in the art may be used for the hole blocking layer.
상기 전자수송층은 전자의 수송을 원활하게 하는 역할을 할 수 있다. 전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al 착물; Alq3를 포함한 착물; 유기 라디칼 화합물; 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다. The electron transport layer may play a role in facilitating the transport of electrons. The electron transport material is a material that can easily inject electrons from the cathode and transfer them to the light-emitting layer, and a material with high mobility for electrons is suitable. Specific examples include Al complex of 8-hydroxyquinoline; Complex containing Alq 3 ; organic radical compounds; Hydroxyflavone-metal complexes, etc., but are not limited to these.
상기 전자주입층은 전자의 주입을 원활하게 하는 역할을 할 수 있다. 전자 주입 물질로는 전자를 수송하는 능력을 갖고, 음극으로부터의 전자주입 효과, 발광층 또는 발광 재료에 대하여 우수한 전자주입 효과를 가지며, 발광층에서 생성된 여기자의 정공주입층으로의 이동을 방지하고, 또한, 박막형성능력이 우수한 화합물이 바람직하다. 구체적으로는 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란 다이옥사이드, 옥사졸, 옥사다이아졸, 트리아졸, 이미다졸, 페릴렌테트라카복실산, 프레오레닐리덴 메탄, 안트론 등과 그들의 유도체, 금속 착체 화합물 및 함질소 5원환 유도체 등이 있으나, 이에 한정되지 않는다. The electron injection layer may serve to facilitate injection of electrons. The electron injection material has the ability to transport electrons, has an excellent electron injection effect from the cathode, a light emitting layer or a light emitting material, prevents movement of excitons generated in the light emitting layer to the hole injection layer, and also has an excellent electron injection effect from the cathode to the light emitting layer or light emitting material. , Compounds with excellent thin film forming ability are preferred. Specifically, fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, preorenylidene methane, anthrone, etc. and their derivatives, metals. These include, but are not limited to, complex compounds and nitrogen-containing five-membered ring derivatives.
상기 금속 착체 화합물로서는 8-하이드록시퀴놀리나토 리튬, 비스(8-하이드록시퀴놀리나토)아연, 비스(8-하이드록시퀴놀리나토)구리, 비스(8-하이드록시퀴놀리나토)망간, 트리스(8-하이드록시퀴놀리나토)알루미늄, 트리스(2-메틸-8-하이드록시퀴놀리나토)알루미늄, 트리스(8-하이드록시퀴놀리나토)갈륨, 비스(10-하이드록시벤조[h]퀴놀리나토)베릴륨, 비스(10-하이드록시벤조[h]퀴놀리나토)아연, 비스(2-메틸-8-퀴놀리나토)클로로갈륨, 비스(2-메틸-8-퀴놀리나토)(o-크레졸라토)갈륨, 비스(2-메틸-8-퀴놀리나토)(1-나프톨라토)알루미늄, 비스(2-메틸-8-퀴놀리나토)(2-나프톨라토)갈륨 등이 있으나, 이에 한정되지 않는다.Examples of the metal complex compounds include 8-hydroxyquinolinato lithium, bis(8-hydroxyquinolinato)zinc, bis(8-hydroxyquinolinato)copper, bis(8-hydroxyquinolinato)manganese, Tris(8-hydroxyquinolinato)aluminum, Tris(2-methyl-8-hydroxyquinolinato)aluminum, Tris(8-hydroxyquinolinato)gallium, bis(10-hydroxybenzo[h] Quinolinato)beryllium, bis(10-hydroxybenzo[h]quinolinato)zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato)( o-cresolato) gallium, bis(2-methyl-8-quinolinato)(1-naphtolato) aluminum, bis(2-methyl-8-quinolinato)(2-naphtolato) gallium, etc. It is not limited to this.
본 발명에 따른 유기 발광 소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic light emitting device according to the present invention may be a front emitting type, a back emitting type, or a double-sided emitting type depending on the material used.
이하에서, 실시예를 통하여 본 명세서를 더욱 상세하게 설명한다. 그러나, 이하의 실시예는 본 명세서를 예시하기 위한 것일 뿐, 본 명세서를 한정하기 위한 것은 아니다.Below, the present specification will be described in more detail through examples. However, the following examples are only for illustrating the present specification and are not intended to limit the present specification.
<< 합성예Synthesis example >>
합성예Synthesis example 1. 화합물 1의 합성 1. Synthesis of Compound 1
합성예Synthesis example 1-1. 화합물 1- 1-1. Compound 1- a 의of a 합성 synthesis
1-브로모-2-플루오로디벤조[b,d]퓨란 (80g, 302mmol)과 (5-클로로-2-하이드록시페닐)보론산 (52.0g, 302mml)을 테트라하이드로퓨란(THF, 1500ml)에 녹인 후, Pd(PPh3)4 (6.97g, 6.0 mmol)와 2M K2CO3 수용액 300ml를 넣고 24시간 동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 1-a (63g, 수율 67%)를 얻었다.1-Bromo-2-fluorodibenzo[b,d]furan (80g, 302mmol) and (5-chloro-2-hydroxyphenyl)boronic acid (52.0g, 302mml) were dissolved in tetrahydrofuran (THF, 1500ml). After dissolving in , Pd(PPh 3 ) 4 (6.97g, 6.0 mmol) and 300ml of 2M K 2 CO 3 aqueous solution were added and stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure and purified using column chromatography to obtain compound 1-a (63 g, yield 67%).
합성예Synthesis example 1-2. 화합물 1-b의 합성 1-2. Synthesis of compound 1-b
화합물 1-a (63g, 201mmol)을 디메틸포름아미드(DMF, 1000ml)에 녹인 후, K2CO3 (83.5g, 604mmol)을 넣고, 2시간 동안 환류교반하였다. 반응 용액을 식힌 후, 증류수 3L에 부어서 고체를 생성시켰다. 고체를 필터한 후 클로로포름에 녹여 물로 여러 번 추출한 후 유기층을 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 1-b (46g, 78%)를 얻었다.Compound 1-a (63g, 201mmol) was dissolved in dimethylformamide (DMF, 1000ml), then K 2 CO 3 (83.5g, 604mmol) was added, and the mixture was refluxed and stirred for 2 hours. After cooling the reaction solution, it was poured into 3L of distilled water to produce a solid. The solid was filtered, dissolved in chloroform, extracted with water several times, and the organic layer was dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure and purified using column chromatography to obtain compound 1-b (46 g, 78%).
합성예Synthesis example 1-3. 화합물 1의 합성 1-3. Synthesis of Compound 1
화합물 1-b (46g, 157mmol)와 비스(피나콜라토)디보론 (48g, 189mmol), 포타슘아세테이트(KOAc) (31g, 314mmol)을 플라스크에 다이옥산(Dioxane) 400ml와 함께 넣어 분산시켰다. 비스(디벤질리덴아세톤)팔라듐(0) (Pd(dba)2) (1.81g, 3.1mmol), 트리시클로헥실포스핀(PCy3) (1.76g, 6.3mmol)을 넣어준 후 24시간 동안 환류교반 하였다. 반응 종료 후 다이옥산(Dioxane)을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 화합물 1를 얻었다. (42g, 수율 70%)Compound 1-b (46g, 157mmol), bis(pinacolato)diborone (48g, 189mmol), and potassium acetate (KOAc) (31g, 314mmol) were dispersed in a flask along with 400ml of dioxane. Bis(dibenzylideneacetone)palladium(0) (Pd(dba) 2 ) (1.81g, 3.1mmol) and tricyclohexylphosphine (PCy 3 ) (1.76g, 6.3mmol) were added and refluxed for 24 hours. Stirred. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, extraction was performed three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Compound 1 was obtained by purification using column chromatography. (42g, yield 70%)
합성예Synthesis example 2. 화합물 2의 합성 2. Synthesis of Compound 2
합성예Synthesis example 2-1. 화합물 2-a의 합성 2-1. Synthesis of compound 2-a
합성예 1-1에서 4-브로모-3-플루오로디벤조[b,d]퓨란과 2-하이드록시페닐 보론산을 이용하여 동일한 방법으로 화합물 2-a를 얻었다.Compound 2-a was obtained in the same manner as in Synthesis Example 1-1 using 4-bromo-3-fluorodibenzo[b,d]furan and 2-hydroxyphenyl boronic acid.
합성예Synthesis example 2-2. 화합물 2-b의 합성 2-2. Synthesis of compound 2-b
합성예 1-2에서 화합물 2-a를 이용하여 동일한 방법으로 화합물 2-b를 얻었다.Compound 2-b was obtained in the same manner as Compound 2-a in Synthesis Example 1-2.
합성예Synthesis example 2-3. 화합물 2-c의 합성 2-3. Synthesis of compound 2-c
화합물 2-b (1 eq) 을 DMF (2000 ml)에 녹인 후, DMF 500ml에 녹인 N-브로모숙신이미드 (1 eq)을 천천히 적가하였다. 상온에서 2시간 교반 후 물 3000ml를 적가하였다. 고체가 생성되면 필터 후 클로로포름에 녹여 증류수로 여러 번 추출하였다. 유기층을 무수황산마그네슘으로 건조 후 감압 증류하여 용매를 제거하였다. 컬럼크로마토그래피를 통해 정제하여 화합물 2-c를 얻었다. (수율 75%)Compound 2-b (1 eq) was dissolved in DMF (2000 ml), and then N-bromosuccinimide (1 eq) dissolved in 500 ml of DMF was slowly added dropwise. After stirring at room temperature for 2 hours, 3000ml of water was added dropwise. When a solid was formed, it was filtered, dissolved in chloroform, and extracted several times with distilled water. The organic layer was dried over anhydrous magnesium sulfate and then distilled under reduced pressure to remove the solvent. Compound 2-c was obtained by purification through column chromatography. (yield 75%)
합성예Synthesis example 2-4. 화합물 2의 합성 2-4. Synthesis of Compound 2
합성예 1-3에서 화합물 2-c를 이용하여 동일한 방법으로 화합물 2를 얻었다.Compound 2 was obtained in the same manner as Compound 2-c in Synthesis Example 1-3.
합성예Synthesis example 3. 화합물 3의 합성 3. Synthesis of Compound 3
합성예Synthesis example 3-1. 화합물 3-a의 합성 3-1. Synthesis of compound 3-a
합성예 1-1에서 4-브로모-1-클로로-3-플루오로디벤조[b,d]퓨란과 2-하이드록시페닐보론산을 이용하여 동일한 방법으로 화합물 3-a를 얻었다.Compound 3-a was obtained in the same manner as in Synthesis Example 1-1 using 4-bromo-1-chloro-3-fluorodibenzo[b,d]furan and 2-hydroxyphenylboronic acid.
합성예Synthesis example 3-2. 화합물 3-b의 합성 3-2. Synthesis of compound 3-b
합성예 1-2에서 화합물 3-a를 이용하여 동일한 방법으로 화합물 3-b를 얻었다.Compound 3-b was obtained in the same manner as Compound 3-a in Synthesis Example 1-2.
합성예Synthesis example 3-3. 화합물 3의 합성 3-3. Synthesis of Compound 3
합성예 1-3에서 화합물 3-b를 이용하여 동일한 방법으로 화합물 3을 얻었다.Compound 3 was obtained in the same manner as Compound 3-b in Synthesis Example 1-3.
합성예Synthesis example 4. 화합물 4의 합성 4. Synthesis of Compound 4
합성예Synthesis example 4-1. 화합물 4-a의 합성 4-1. Synthesis of compound 4-a
합성예 1-1에서 4-브로모-3-플루오로디벤조[b,d]퓨란을 이용하여 동일한 방법으로 화합물 4-a를 얻었다.Compound 4-a was obtained in the same manner as in Synthesis Example 1-1 using 4-bromo-3-fluorodibenzo[b,d]furan.
합성예Synthesis example 4-2. 화합물 4-b의 합성 4-2. Synthesis of compound 4-b
합성예 1-2에서 화합물 4-a를 이용하여 동일한 방법으로 화합물 4-b를 얻었다.Compound 4-b was obtained in the same manner as Compound 4-a in Synthesis Example 1-2.
합성예Synthesis example 4-3. 화합물 4의 합성 4-3. Synthesis of Compound 4
합성예 1-3에서 화합물 4-b를 이용하여 동일한 방법으로 화합물 4를 얻었다.Compound 4 was obtained in the same manner as Compound 4-b in Synthesis Example 1-3.
합성예Synthesis example 5. 화합물 5의 합성 5. Synthesis of Compound 5
합성예Synthesis example 5-1. 화합물 5-a의 합성 5-1. Synthesis of compound 5-a
합성예 1-1에서 4-브로모-3-플루오로디벤조[b,d]퓨란과 (6-클로로-2-하이드록시페닐)보론산을 이용하여 동일한 방법으로 화합물 5-a를 얻었다.Compound 5-a was obtained in the same manner as in Synthesis Example 1-1 using 4-bromo-3-fluorodibenzo[b,d]furan and (6-chloro-2-hydroxyphenyl)boronic acid.
합성예Synthesis example 5-2. 화합물 5-b의 합성 5-2. Synthesis of compound 5-b
합성예 1-2에서 화합물 5-a를 이용하여 동일한 방법으로 화합물 5-b를 얻었다.Compound 5-b was obtained in the same manner as Compound 5-a in Synthesis Example 1-2.
합성예Synthesis example 5-3. 화합물 5의 합성 5-3. Synthesis of compound 5
합성예 1-3에서 화합물 5-b를 이용하여 동일한 방법으로 화합물 5를 얻었다.Compound 5 was obtained in the same manner as Compound 5-b in Synthesis Example 1-3.
합성예Synthesis example 6. 화합물 6의 합성 6. Synthesis of Compound 6
합성예Synthesis example 6-1. 화합물 6-a의 합성 6-1. Synthesis of compound 6-a
합성예 1-1에서 4-브로모-3-플루오로디벤조[b,d]퓨란과 (4-클로로-2-하이드록시페닐)보론산을 이용하여 동일한 방법으로 화합물 6-a를 얻었다.Compound 6-a was obtained in the same manner as in Synthesis Example 1-1 using 4-bromo-3-fluorodibenzo[b,d]furan and (4-chloro-2-hydroxyphenyl)boronic acid.
합성예Synthesis example 6-2. 화합물 6-b의 합성 6-2. Synthesis of compound 6-b
합성예 1-2에서 화합물 6-a를 이용하여 동일한 방법으로 화합물 5-b를 얻었다.Compound 5-b was obtained in the same manner as Compound 6-a in Synthesis Example 1-2.
합성예Synthesis example 6-3. 화합물 6의 합성 6-3. Synthesis of compound 6
합성예 1-3에서 화합물 6-b를 이용하여 동일한 방법으로 화합물 6을 얻었다.Compound 6 was obtained in the same manner as Compound 6-b in Synthesis Example 1-3.
합성예Synthesis example 7. 화합물 7의 합성 7. Synthesis of Compound 7
합성예Synthesis example 7-1. 화합물 7-a의 합성 7-1. Synthesis of compound 7-a
합성예 1-1에서 화합물 5와 1-브로모-4-클로로벤젠을 이용하여 동일한 방법으로 화합물 7-a를 합성하였다. Compound 7-a was synthesized in the same manner as in Synthesis Example 1-1 using Compound 5 and 1-bromo-4-chlorobenzene.
합성예Synthesis example 7-2. 화합물 7의 합성 7-2. Synthesis of compound 7
합성예 1-3에서 화합물 7-a를 이용하여 동일한 방법으로 화합물 7을 합성하였다.Compound 7 was synthesized in the same manner as Compound 7-a in Synthesis Example 1-3.
합성예Synthesis example 8. 화합물 8의 합성 8. Synthesis of Compound 8
합성예Synthesis example 8-1. 화합물 8-a의 합성 8-1. Synthesis of compound 8-a
디벤조[b,d]티오펜-2-올 (1 eq) 을 DMF (2000ml)에 녹인 후, DMF 500ml에 녹인 N-브로모숙신이미드 (1 eq)을 천천히 적가하였다. 상온에서 2시간 교반 후 물 3000ml를 적가하였다. 고체가 생성되면 필터 후 클로로포름에 녹여 증류수로 여러 번 추출하였다. 유기층을 무수황산마그네슘으로 건조 후 감압 증류하여 용매를 제거하였다. 컬럼크로마토그래피를 통해 정제하여 화합물 8-a를 얻었다.Dibenzo[b,d]thiophen-2-ol (1 eq) was dissolved in DMF (2000ml), and N-bromosuccinimide (1 eq) dissolved in 500ml DMF was slowly added dropwise. After stirring at room temperature for 2 hours, 3000ml of water was added dropwise. When a solid was formed, it was filtered, dissolved in chloroform, and extracted several times with distilled water. The organic layer was dried over anhydrous magnesium sulfate and then distilled under reduced pressure to remove the solvent. Compound 8-a was obtained by purification through column chromatography.
합성예Synthesis example 8-2. 화합물 8-b의 합성 8-2. Synthesis of compound 8-b
합성예 1-1에서 화합물 8-a와 (5-클로로-2-플루오로페닐)보론산을 이용하여 동일한 방법으로 화합물 8-b를 얻었다.Compound 8-b was obtained in the same manner as in Synthesis Example 1-1 using compound 8-a and (5-chloro-2-fluorophenyl)boronic acid.
합성예Synthesis example 8-3. 화합물 8-c의 합성 8-3. Synthesis of compound 8-c
합성예 1-2에서 화합물 8-b를 이용하여 동일한 방법으로 화합물 8-c를 얻었다.Compound 8-c was obtained in the same manner as Compound 8-b in Synthesis Example 1-2.
합성예Synthesis example 8-4. 화합물 8의 합성 8-4. Synthesis of compound 8
합성예 1-3에서 화합물 8-c를 이용하여 동일한 방법으로 화합물 8을 얻었다.Compound 8 was obtained in the same manner as Compound 8-c in Synthesis Example 1-3.
합성예Synthesis example 9. 화합물 9의 합성 9. Synthesis of Compound 9
합성예Synthesis example 9-1. 화합물 9-a의 합성 9-1. Synthesis of compound 9-a
합성예 1-1에서 4-브로모-3-플루오로디메틸플루오렌과 (5-클로로-2-하이드록시페닐)보론산을 이용하여 동일한 방법으로 화합물 9-a를 얻었다.Compound 9-a was obtained in the same manner as in Synthesis Example 1-1 using 4-bromo-3-fluorodimethylfluorene and (5-chloro-2-hydroxyphenyl)boronic acid.
합성예Synthesis example 9-2. 화합물 9-b의 합성 9-2. Synthesis of compound 9-b
합성예 1-2에서 화합물 9-a를 이용하여 동일한 방법으로 화합물 9-b를 얻었다.Compound 9-b was obtained in the same manner as Compound 9-a in Synthesis Example 1-2.
합성예Synthesis example 9-3. 화합물 9의 합성 9-3. Synthesis of compound 9
합성예 1-3에서 화합물 9-b를 이용하여 동일한 방법으로 화합물 9를 얻었다.Compound 9 was obtained in the same manner as Compound 9-b in Synthesis Example 1-3.
합성예Synthesis example 10. 화합물 10의 합성 10. Synthesis of Compound 10
합성예Synthesis example 10-1. 화합물 10-a의 합성 10-1. Synthesis of compound 10-a
합성예 1-1에서 1-브로모-2-아이오도-3-플루오로벤젠을 이용하여 동일한 방법으로 화합물 10-a를 얻었다. Compound 10-a was obtained in the same manner as in Synthesis Example 1-1 using 1-bromo-2-iodo-3-fluorobenzene.
합성예Synthesis example 10-2. 화합물 10-b의 합성 10-2. Synthesis of compound 10-b
합성예 1-2에서 화합물 10-a를 이용하여 동일한 방법으로 화합물 10-b를 얻었다.Compound 10-b was obtained in the same manner as Compound 10-a in Synthesis Example 1-2.
합성예Synthesis example 10-3. 화합물 10-c의 합성 10-3. Synthesis of compound 10-c
합성예 1-1에서 화합물 10-b와 2-나이트로보론산을 이용하여 동일한 방법으로 화합물 10-c를 얻었다.Compound 10-c was obtained in the same manner as in Synthesis Example 1-1 using compound 10-b and 2-nitroboronic acid.
합성예Synthesis example 10-4. 화합물 10-d의 합성 10-4. Synthesis of compound 10-d
화합물 10-c (1 eq)와 PPh3 (3 eq)를 o-디클로로벤젠 600ml에 녹인 후 8시간 환류교반하였다. 반응 종료 후 감압증류하여 용매를 제거 후 클로로포름에 녹여서 증류수로 여러 번 추출하였다. 유기층을 취해서 무수황산마그네슘으로 건조시킨 후 감압증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 화합물 10-d (수율 60%)을 얻었다.Compound 10-c (1 eq) and PPh 3 (3 eq) were dissolved in 600 ml of o-dichlorobenzene and stirred under reflux for 8 hours. After completion of the reaction, the solvent was removed by distillation under reduced pressure, dissolved in chloroform, and extracted several times with distilled water. The organic layer was taken, dried over anhydrous magnesium sulfate, and then distilled under reduced pressure to remove chloroform. Compound 10-d (yield 60%) was obtained by purification using column chromatography.
합성예Synthesis example 10-5. 화합물 10-e의 합성 10-5. Synthesis of compound 10-e
화합물 10-d (1 eq)과 아이오도벤젠 (1 eq) 를 DMF 250ml에 녹인 후, CS2CO3 (2 eq)과 CuI (0.1 eq)을 넣어주었다. 120℃로 승온한 뒤 16시간 동안 교반하였다. 반응용액을 식힌 후 에틸아세테이트를 1L 넣어 준 후 분별깔대기로 옮겨 암모니아 수용액으로 1회 추출, 증류수 1L로 총 3회 추출하였다. 유기층을 모아서 무수황산마그네슘을 처리하여 물을 제거해 준 후, 감압 증류하였다. 컬럼크로마토그래피를 이용하여 정제하여 화합물 10-e를 얻었다. (수율 57%)Compound 10-d (1 eq) and iodobenzene (1 eq) were dissolved in 250ml of DMF, and then CS 2 CO 3 (2 eq) and CuI (0.1 eq) were added. The temperature was raised to 120°C and stirred for 16 hours. After cooling the reaction solution, 1L of ethyl acetate was added, and then it was transferred to a separatory funnel and extracted once with an aqueous ammonia solution and a total of three times with 1L of distilled water. The organic layer was collected, treated with anhydrous magnesium sulfate to remove water, and then distilled under reduced pressure. Compound 10-e was obtained by purification using column chromatography. (yield 57%)
합성예Synthesis example 10-6. 화합물 10의 합성 10-6. Synthesis of compound 10
합성예 1-3에서 화합물 10-e를 이용하여 동일한 방법으로 화합물 10을 얻었다.Compound 10 was obtained in the same manner as Compound 10-e in Synthesis Example 1-3.
합성예Synthesis example 11. 화합물 11의 합성 11. Synthesis of Compound 11
합성예Synthesis example 11-1. 화합물 11-a의 합성 11-1. Synthesis of compound 11-a
합성예 1-1에서 1-브로모-2-플루오로디메틸플루오렌을 이용하여 동일한 방법으로 화합물 11-a를 얻었다.Compound 11-a was obtained in the same manner as in Synthesis Example 1-1 using 1-bromo-2-fluorodimethylfluorene.
합성예Synthesis example 11-2. 화합물 11-b의 합성 11-2. Synthesis of compound 11-b
합성예 1-2에서 화합물 11-a를 이용하여 동일한 방법으로 화합물 11-b를 얻었다.Compound 11-b was obtained in the same manner as Compound 11-a in Synthesis Example 1-2.
합성예Synthesis example 11-3. 화합물 11의 합성 11-3. Synthesis of compound 11
합성예 1-3에서 화합물 11-b를 이용하여 동일한 방법으로 화합물 11를 얻었다.Compound 11 was obtained in the same manner as Compound 11-b in Synthesis Example 1-3.
합성예Synthesis example 12. BH-A의 합성 12. Synthesis of BH-A
합성예Synthesis example 12-1. 화합물 12-a의 합성 12-1. Synthesis of compound 12-a
2-브로모안트라센 (100 g, 389mmol)와 1-나프탈렌보론산 (66.9g, 389mmol)을 THF (2000ml)에 녹인 후, Pd(PPh3)4 (9.0g, 7.8mmol)와 2M K2CO3 수용액 400ml를 넣고 24시간 동안 환류 교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 12-a (94g, 수율 80%)를 얻었다.After dissolving 2-bromoanthracene (100 g, 389mmol) and 1-naphthaleneboronic acid (66.9g, 389mmol) in THF (2000ml), Pd(PPh 3 ) 4 (9.0g, 7.8mmol) and 2M K 2 CO 3 400ml of aqueous solution was added and stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure and purified using column chromatography to obtain compound 12-a (94 g, yield 80%).
합성예Synthesis example 12-2. 화합물 12-b의 합성 12-2. Synthesis of compound 12-b
화합물 10-a (94g, 311mmol)를 DMF 1200ml에 녹인 후, DMF 300ml에 녹인 N-브로모숙신이미드 (55.3g, 311mmol)을 천천히 적가하였다. 상온에서 2시간 교반 후 물 3000ml를 적가하였다. 고체가 생성되면 필터 후 클로로포름에 녹여 증류수로 여러 번 추출하였다. 에틸아세테이트에서 재결정하여 화합물 10-b를 얻었다. (73g, 수율 61%)Compound 10-a (94g, 311mmol) was dissolved in 1200ml of DMF, and then N-bromosuccinimide (55.3g, 311mmol) dissolved in 300ml of DMF was slowly added dropwise. After stirring at room temperature for 2 hours, 3000ml of water was added dropwise. When a solid was formed, it was filtered, dissolved in chloroform, and extracted several times with distilled water. Compound 10-b was obtained by recrystallization from ethyl acetate. (73g, yield 61%)
합성예Synthesis example 12-3. 화합물 12-c의 합성 12-3. Synthesis of compound 12-c
화합물 10-b (73 g, 189mmol)와 화합물 1 (72.6 g, 189mmol) 을 THF (1000ml)에 녹인 후, Pd(PPh3)4 (4.4g, 3.8mmol)와 2M K2CO3 수용액 200ml를 넣고 24시간 동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하게 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 12-c (52g, 수율 72%)를 얻었다.After dissolving Compound 10-b (73 g, 189 mmol) and Compound 1 (72.6 g, 189 mmol) in THF (1000 ml), Pd(PPh 3 ) 4 (4.4 g, 3.8 mmol) and 200 ml of 2M K 2 CO 3 aqueous solution were added. Added and stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure and purified using column chromatography to obtain compound 12-c (52 g, yield 72%).
합성예Synthesis example 12-4. 화합물 12-d의 합성 12-4. Synthesis of compound 12-d
화합물 12-c (52g, 136mmol)를 DMF 600ml에 녹인 후, DMF 100ml에 녹인 N-브로모숙신이미드 (24.2g, 136mmol)을 천천히 적가하였다. 상온에서 2시간 교반 후 물 1500ml를 적가하였다. 고체가 생성되면 필터 후 클로로포름에 녹여 증류수로 여러 번 추출하였다. 에틸아세테이트에서 재결정하여 화합물 12-d을 얻었다. (41g, 수율 66%)Compound 12-c (52g, 136mmol) was dissolved in 600ml of DMF, and then N-bromosuccinimide (24.2g, 136mmol) dissolved in 100ml of DMF was slowly added dropwise. After stirring at room temperature for 2 hours, 1500 ml of water was added dropwise. When a solid was formed, it was filtered, dissolved in chloroform, and extracted several times with distilled water. Compound 12-d was obtained by recrystallization from ethyl acetate. (41g, yield 66%)
합성예Synthesis example 12-5. BH-A의 합성 12-5. Synthesis of BH-A
화합물 12-d (41 g, 64 mmol)와 페닐보론산 (7.8 g, 64 mmol) 을 THF (500ml)에 녹인 후, Pd(PPh3)4 (1.5g, 1.3mmol)와 2M K2CO3 수용액 100ml를 넣고 24시간 동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하게 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 BH-A (32g, 수율 78%)를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 636.7, exp. m/s (M+H) 637.7]Compound 12-d (41 g, 64 mmol) and phenylboronic acid (7.8 g, 64 mmol) were dissolved in THF (500ml), then Pd(PPh 3 ) 4 (1.5g, 1.3mmol) and 2M K 2 CO 3 100 ml of aqueous solution was added and stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure and purified using column chromatography to obtain compound BH-A (32 g, yield 78%). The final compound was confirmed by mass. [cal. m/s: 636.7, exp. m/s (M+H) 637.7]
합성예Synthesis example 13. BH-B의 합성 13. Synthesis of BH-B
합성예 12에서 페닐보론산 대신 1-나프탈렌보론산을 이용하여 동일한 방법으로 BH-B를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]BH-B was obtained in the same manner as in Synthesis Example 12, using 1-naphthaleneboronic acid instead of phenylboronic acid. The final compound was confirmed by mass. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]
합성예Synthesis example 14. BH-C의 합성 14. Synthesis of BH-C
합성예 12에서 페닐보론산 대신 2-나프탈렌보론산을 이용하여 동일한 방법으로 BH-C를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]BH-C was obtained in the same manner as in Synthesis Example 12, using 2-naphthaleneboronic acid instead of phenylboronic acid. The final compound was confirmed by mass. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]
합성예Synthesis example 15. BH-D의 합성 15. Synthesis of BH-D
합성예 12에서 페닐보론산 대신 9-페난트릴보론산을 이용하여 동일한 방법으로 BH-D를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 736.9, exp. m/s (M+H) 737.9]BH-D was obtained in the same manner as in Synthesis Example 12, using 9-phenanthrylboronic acid instead of phenylboronic acid. The final compound was confirmed by mass. [cal. m/s: 736.9, exp. m/s (M+H) 737.9]
합성예Synthesis example 16. BH-E의 합성 16. Synthesis of BH-E
합성예 12에서 화합물 1 대신 화합물 2를 이용하여 동일한 방법으로 BH-E를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 636.8, exp. m/s (M+H) 637.8]BH-E was obtained in the same manner as in Synthesis Example 12, using Compound 2 instead of Compound 1. The final compound was confirmed by mass. [cal. m/s: 636.8, exp. m/s (M+H) 637.8]
합성예Synthesis example 17. BH-F의 합성 17. Synthesis of BH-F
합성예 12에서 페닐보론산 대신 1-나프탈렌보론산을, 화합물 1 대신 화합물 2를 이용하여 동일한 방법으로 BH-F를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]BH-F was obtained in the same manner as in Synthesis Example 12, using 1-naphthaleneboronic acid instead of phenylboronic acid and Compound 2 instead of Compound 1. The final compound was confirmed by mass. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]
합성예Synthesis example 18. BH-G의 합성 18. Synthesis of BH-G
합성예 12에서 페닐보론산 대신 2-나프탈렌보론산을, 화합물 1 대신 화합물 3을 이용하여 동일한 방법으로 BH-G를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]BH-G was obtained in the same manner as in Synthesis Example 12, using 2-naphthaleneboronic acid instead of phenylboronic acid and Compound 3 instead of Compound 1. The final compound was confirmed by mass. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]
합성예Synthesis example 19. BH-H의 합성 19. Synthesis of BH-H
합성예 12에서 1-나프탈렌보론산 대신 9-페난트릴보론산을, 화합물 1 대신 화합물 3을 이용하여 동일한 방법으로 BH-H를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]BH-H was obtained in the same manner as in Synthesis Example 12, using 9-phenanthrylboronic acid instead of 1-naphthaleneboronic acid and Compound 3 instead of Compound 1. The final compound was confirmed by mass. [cal. m/s: 686.8, exp. m/s (M+H) 687.8]
합성예Synthesis example 20. BH-I의 합성 20. Synthesis of BH-I
합성예 12에서 1-나프탈렌보론산 대신 페닐보론산을, 화합물 1 대신 화합물 4를 이용하여 동일한 방법으로 BH-I를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 586.7, exp. m/s (M+H) 587.7]BH-I was obtained in the same manner as in Synthesis Example 12, using phenylboronic acid instead of 1-naphthaleneboronic acid and compound 4 instead of compound 1. The final compound was confirmed by mass. [cal. m/s: 586.7, exp. m/s (M+H) 587.7]
합성예Synthesis example 21. BH-J의 합성 21. Synthesis of BH-J
합성예 12에서 1-나프탈렌보론산 대신 페닐보론산을, 화합물 1 대신 화합물 5를 이용하여 동일한 방법으로 BH-J를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 586.7, exp. m/s (M+H) 587.7]BH-J was obtained in the same manner as in Synthesis Example 12, using phenylboronic acid instead of 1-naphthaleneboronic acid and compound 5 instead of compound 1. The final compound was confirmed by mass. [cal. m/s: 586.7, exp. m/s (M+H) 587.7]
합성예Synthesis example 22. BH-K의 합성 22. Synthesis of BH-K
합성예 12에서 1-나프탈렌보론산 대신 페닐보론산을, 화합물 1 대신 화합물 6을 이용하여 동일한 방법으로 BH-K를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 586.7, exp. m/s (M+H) 587.7]BH-K was obtained in the same manner as in Synthesis Example 12, using phenylboronic acid instead of 1-naphthaleneboronic acid and Compound 6 instead of Compound 1. The final compound was confirmed by mass. [cal. m/s: 586.7, exp. m/s (M+H) 587.7]
합성예Synthesis example 23. BH-L의 합성 23. Synthesis of BH-L
합성예 12에서 화합물 1 대신 화합물 7을 이용하여 동일한 방법으로 BH-L을 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 712.8, exp. m/s (M+H) 713.8]BH-L was obtained in the same manner as in Synthesis Example 12, using compound 7 instead of compound 1. The final compound was confirmed by mass. [cal. m/s: 712.8, exp. m/s (M+H) 713.8]
합성예Synthesis example 24. BH-M의 합성 24. Synthesis of BH-M
합성예 12에서 화합물 1 대신 화합물 8을 이용하여 동일한 방법으로 BH-M을 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 652.8, exp. m/s (M+H) 653.8]BH-M was obtained in the same manner as in Synthesis Example 12, using compound 8 instead of compound 1. The final compound was confirmed by mass. [cal. m/s: 652.8, exp. m/s (M+H) 653.8]
합성예Synthesis example 25. BH-N의 합성 25. Synthesis of BH-N
합성예 12에서 화합물 1 대신 화합물 9를 이용하여 동일한 방법으로 BH-N를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 662.8, exp. m/s (M+H) 663.8]BH-N was obtained in the same manner as in Synthesis Example 12, using Compound 9 instead of Compound 1. The final compound was confirmed by mass. [cal. m/s: 662.8, exp. m/s (M+H) 663.8]
합성예Synthesis example 26. BH-O의 합성 26. Synthesis of BH-O
합성예 12에서 화합물 1 대신 화합물 10을 이용하여 동일한 방법으로 BH-O를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 711.9, exp. m/s (M+H) 712.9]BH-O was obtained in the same manner as in Synthesis Example 12, using Compound 10 instead of Compound 1. The final compound was confirmed by mass. [cal. m/s: 711.9, exp. m/s (M+H) 712.9]
합성예Synthesis example 27. BH-P의 합성 27. Synthesis of BH-P
합성예 12에서 화합물 1 대신 화합물 11을 이용하여 동일한 방법으로 BH-P를 얻었다. 최종 화합물은 mass로 확인했다. [cal. m/s: 662.8, exp. m/s (M+H) 663.8]BH-P was obtained in the same manner as in Synthesis Example 12, using Compound 11 instead of Compound 1. The final compound was confirmed by mass. [cal. m/s: 662.8, exp. m/s (M+H) 663.8]
합성예Synthesis example 28. BH-Q의 합성 28. Synthesis of BH-Q
BH-A (20g)와 AlCl3(4g)을 C6D6 (600ml)에 넣고 2시간 교반하였다. 반응 종료 후 D2O (30ml)를 넣고 30분 교반한 뒤 트리메틸아민(trimethylamine) (2.4ml)를 적가하였다. 반응액을 분액 깔대기에 옮기고, 물과 톨루엔으로 추출하였다. 추출액을 MgSO4로 건조 후, 에틸아세테이트로 재결정하여 BH-Q를 얻었다. (15g, 수율 75%) 최종 화합물은 mass로 확인했다. 중수소 치환반응에서는 분자량이 분포로 나타나게 된다. [cal. m/s: 664.9, exp. m/s (M+H) 658 ~ 665 ]BH-A (20g) and AlCl 3 (4g) were added to C 6 D 6 (600ml) and stirred for 2 hours. After completion of the reaction, D 2 O (30ml) was added, stirred for 30 minutes, and trimethylamine (2.4ml) was added dropwise. The reaction solution was transferred to a separatory funnel and extracted with water and toluene. The extract was dried with MgSO 4 and recrystallized with ethyl acetate to obtain BH-Q. (15g, yield 75%) The final compound was confirmed by mass. In the deuterium substitution reaction, molecular weight appears as a distribution. [cal. m/s: 664.9, exp. m/s (M+H) 658 ~ 665 ]
합성예Synthesis example 29. 화합물 12의 합성 29. Synthesis of compound 12
합성예 28에서 2-클로로안트라센을 이용하여 동일한 방법으로 화합물 12를 얻었다. 최종 화합물은 mass로 확인했다. 중수소 치환반응에서는 분자량이 분포로 나타나게 된다. [cal. m/s: 221.7, exp. m/s (M+H) 220 ~ 222]Compound 12 was obtained in the same manner as in Synthesis Example 28 using 2-chloroanthracene. The final compound was confirmed by mass. In the deuterium substitution reaction, molecular weight appears as a distribution. [cal. m/s: 221.7, exp. m/s (M+H) 220 ~ 222]
합성예Synthesis example 29. BH-R의 합성 29. Synthesis of BH-R
합성예 12에서 2-브로모안트라센 대신에 화합물 12를 이용하여 동일한 방법으로 BH-R를 얻었다. 최종 화합물은 mass로 확인했다. 중수소 치환반응에서는 분자량이 분포로 나타나게 된다. [cal. m/s: 643.8, exp. m/s (M+H) 642 ~ 644 ]BH-R was obtained in the same manner as in Synthesis Example 12, using Compound 12 instead of 2-bromoanthracene. The final compound was confirmed by mass. In the deuterium substitution reaction, molecular weight appears as a distribution. [cal. m/s: 643.8, exp. m/s (M+H) 642 ~ 644 ]
합성예Synthesis example 30. BH-S의 합성 30. Synthesis of BH-S
합성예 12에서 2-브로모안트라센 대신에 화합물 12를, 화합물 1 대신에 화합물 9를 이용하여 동일한 방법으로 BH-S를 얻었다. 최종 화합물은 mass로 확인했다. 중수소 치환반응에서는 분자량이 분포로 나타나게 된다. [cal. m/s: 669.9, exp. m/s (M+H) 668 ~ 670]BH-S was obtained in the same manner as in Synthesis Example 12, using compound 12 instead of 2-bromoanthracene and compound 9 instead of compound 1. The final compound was confirmed by mass. In the deuterium substitution reaction, molecular weight appears as a distribution. [cal. m/s: 669.9, exp. m/s (M+H) 668 ~ 670]
합성예Synthesis example 31. BH-T의 합성 31. Synthesis of BH-T
합성예 12에서 2-브로모안트라센 대신에 화합물 12를, 화합물 1 대신에 화합물 10을 이용하여 동일한 방법으로 BH-T를 얻었다. 최종 화합물은 mass로 확인했다. 중수소 치환반응에서는 분자량이 분포로 나타나게 된다. [cal. m/s: 718.9, exp. m/s (M+H) 717 ~ 719 ]BH-T was obtained in the same manner as in Synthesis Example 12, using compound 12 instead of 2-bromoanthracene and compound 10 instead of compound 1. The final compound was confirmed by mass. In the deuterium substitution reaction, molecular weight appears as a distribution. [cal. m/s: 718.9, exp. m/s (M+H) 717 ~ 719 ]
<< 실험예Experiment example . 유기 발광 소자의 제조>. Manufacturing of organic light emitting devices>
실시예Example 1. One.
ITO(indium tin oxide)가 150 nm의 두께로 박막 코팅된 유리 기판을 세제를 녹인 증류수에 넣고 초음파로 세척하였다. 이때, 세제로는 피셔사(Fischer Co.) 제품을 사용하였으며, 증류수로는 밀리포어사(Millipore Co.) 제품의 필터(Filter)로 2차로 걸러진 증류수를 사용하였다. ITO를 30분간 세척한 후 증류수로 2회 반복하여 초음파 세척을 10분간 진행하였다. 증류수 세척이 끝난 후, 이소프로필알콜, 아세톤, 메탄올의 용제로 초음파 세척을 하고 건조시킨 후 플라즈마 세정기로 수송시켰다. 또한, 질소 플라즈마를 이용하여 상기 기판을 5분간 세정한 후 진공 증착기로 기판을 수송시켰다. 이렇게 준비된 ITO 투명 전극 위에 하기 HAT-CN 화합물을 5 nm의 두께로 열 진공 증착하여 정공주입층을 형성하였다. 이어서, HTL1을 100 nm의 두께로 열 진공 증착하고, 이어 HTL2를 10 nm의 두께로 열 진공 증착하여 정공수송층을 형성하였다. 이어서, 호스트로서 상기 BH-A 및 도펀트로서 BD-A (중량비 97:3)를 동시에 진공 증착하여 20 nm 두께의 발광층을 형성하였다. 이어서, ETL을 20 nm의 두께로 진공 증착하여 전자수송층을 형성하였다. 이어서, LiF을 0.5 nm의 두께로 진공 증착하여 전자주입층을 형성하였다. 이어서, 알루미늄을 100 nm의 두께로 증착하여 음극을 형성하여 유기 발광 소자를 제조하였다.A glass substrate coated with a thin film of ITO (indium tin oxide) with a thickness of 150 nm was placed in distilled water with a detergent dissolved in it and washed ultrasonically. At this time, a detergent from Fischer Co. was used, and distilled water filtered secondarily using a filter from Millipore Co. was used as distilled water. After washing the ITO for 30 minutes, ultrasonic cleaning was repeated twice with distilled water for 10 minutes. After washing with distilled water, it was ultrasonic washed with solvents of isopropyl alcohol, acetone, and methanol, dried, and then transported to a plasma cleaner. Additionally, the substrate was cleaned for 5 minutes using nitrogen plasma and then transported to a vacuum evaporator. On the ITO transparent electrode prepared in this way, the following HAT-CN compound was thermally vacuum deposited to a thickness of 5 nm to form a hole injection layer. Next, HTL1 was thermally vacuum deposited to a thickness of 100 nm, and then HTL2 was thermally vacuum deposited to a thickness of 10 nm to form a hole transport layer. Subsequently, BH-A as a host and BD-A (weight ratio 97:3) as a dopant were simultaneously vacuum deposited to form a 20 nm thick light emitting layer. Next, ETL was vacuum deposited to a thickness of 20 nm to form an electron transport layer. Subsequently, LiF was vacuum deposited to a thickness of 0.5 nm to form an electron injection layer. Next, aluminum was deposited to a thickness of 100 nm to form a cathode, thereby manufacturing an organic light emitting device.
실시예에서 사용된 화합물의 구조는 하기와 같다.The structures of the compounds used in the examples are as follows.
실시예Example 2 내지 20 및 2 to 20 and 비교예Comparative example 1 내지 3. 1 to 3.
상기 실시예 1에서 발광층의 호스트로서 화합물 BH-A 대신 하기 표 1에 기재된 화합물을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 유기 발광 소자를 제조하였다.An organic light-emitting device was manufactured in the same manner as Example 1, except that the compounds listed in Table 1 below were used as the host of the light-emitting layer instead of compound BH-A.
상기 실시예 1 내지 20 및 비교예 1 내지 3에서 제조한 유기 발광 소자에 있어서, 10 mA/cm2 의 전류밀도에서 구동전압과 발광효율을 측정하였고, 20 mA/cm2 의 전류밀도에서 초기 휘도 대비 95%가 되는 시간(LT)을 측정하여, 그 결과를 하기 표 1에 나타내었다.In the organic light emitting devices manufactured in Examples 1 to 20 and Comparative Examples 1 to 3, the driving voltage and luminous efficiency were measured at a current density of 10 mA/cm 2 , and the initial luminance was measured at a current density of 20 mA/cm 2 The time to reach 95% of the comparison (LT) was measured, and the results are shown in Table 1 below.
본 발명 화학식 1로 표시되는 화합물을 사용한 실시예 1 내지 20은 비교예 1 내지 3에 비하여 모두 저전압 및 고효율의 특성을 나타내었으며, 수명도 우수함을 나타내었다. 또한, 실시예 17 내지 20으로부터 중수소 치환된 화합물을 사용한 소자의 수명이 현저하게 개선되는 것을 확인할 수 있다.Examples 1 to 20 using the compound represented by Formula 1 of the present invention all showed characteristics of low voltage and high efficiency compared to Comparative Examples 1 to 3, and also showed excellent lifespan. Additionally, it can be seen from Examples 17 to 20 that the lifespan of devices using deuterium-substituted compounds is significantly improved.
비교예 1은 화학식 2의 Ar1 수소인 화합물 BH-1을 사용하였으며 실시예 1 내지 20에 비하여 구동전압이 높고 효율 및 수명이 떨어지는 것을 확인할 수 있다. 또한 비교예 2 에서 사용된 화합물 BH-2는 화학식 1에서 중수소를 포함하나, Ar1은 수소인 경우에 해당하며 비교예 1에 비하여 수명의 증가는 가져오나 실시예 대비 짧은 수명을 보인다. Comparative Example 1 used compound BH-1, which is Ar1 hydrogen of Formula 2, and it can be seen that the driving voltage is higher and the efficiency and lifespan are lower than those of Examples 1 to 20. In addition, the compound BH-2 used in Comparative Example 2 contains deuterium in Formula 1, but Ar1 is hydrogen, and has an increased lifespan compared to Comparative Example 1, but has a shorter lifespan compared to the Examples.
비교예 3에서 사용된 화합물 BH-3는 화학식 1에서 O를 포함하는 5환의 축합 헤테로고리 위치에 O를 포함하지 않는 헤테로고리가 결합된 구조를 가지며, N, S 및 O 중 전기음성도가 가장 큰 O를 포함하지 않으므로 전자의 주입이 본원 실시예보다 용이하지 않아, 소자의 효율 및 수명이 떨어지는 것을 확인할 수 있다. 또한, 상기 화합물 BH-3는 안트라센 2, 6번 위치에 아릴이 동시에 치환된 구조를 가지며, 이 경우 분자의 공액 길이가 너무 길어져 도펀트와 유사한 에너지 갭을 갖게 되어 구동전압은 낮아지게 되나 도펀트로의 에너지 전달이 어려워지게 된다. 따라서, Ar1에만 치환되는 것이 구동전압, 효율 및 수명 개선을 가져옴을 확인할 수 있다.Compound BH-3 used in Comparative Example 3 has a structure in which a heterocyclic ring not containing O is bonded to the 5-ring condensed heterocyclic ring containing O in Formula 1, and has the highest electronegativity among N, S and O. Since it does not contain large O, injection of electrons is not as easy as in the embodiment of the present application, and it can be seen that the efficiency and lifespan of the device are reduced. In addition, the compound BH-3 has a structure in which aryl is simultaneously substituted at positions 2 and 6 of anthracene. In this case, the conjugate length of the molecule becomes too long to have an energy gap similar to that of the dopant, resulting in a lower driving voltage, but Energy transfer becomes difficult. Therefore, it can be confirmed that substitution only for Ar1 leads to improvements in driving voltage, efficiency, and lifespan.
1: 기판
2: 양극
3: 발광층
4: 음극
5: 정공주입층
6: 정공수송층
7: 발광층
8: 전자수송층
9: 전자주입층1: substrate
2: anode
3: Light-emitting layer
4: cathode
5: Hole injection layer
6: Hole transport layer
7: Light-emitting layer
8: Electron transport layer
9: Electron injection layer
Claims (14)
[화학식 1]
상기 화학식 1에 있어서,
R1 및 R2는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이고,
Az1 및 Az2 중 어느 하나는 -L10-Ar1이며, 나머지 하나는 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이고,
L1, L2 및 L10은 서로 같거나 상이하고, 각각 독립적으로 직접결합; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴렌기이며,
Ar1은 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이고,
Ar2는 치환 또는 비치환된 탄소수 6 내지 60의 아릴기; 또는 치환 또는 비치환된 이종원소로 O, S 및 N 중 1 이상 포함하는 탄소수 2 내지 60의 헤테로고리기이며,
a는 0 내지 5의 정수이며, b는 0 내지 6의 정수이고,
a가 2 이상일 경우, 2 이상의 R1은 서로 같거나 상이하고,
b가 2 이상일 경우, 2 이상의 R2는 서로 같거나 상이하며,
*는 하기 화학식 2와 결합하고,
[화학식 2]
상기 화학식 2에 있어서,
X는 O, S, NR, 또는 CR'R"이고,
R, R', R" 및 R3는 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 30의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴기이며,
c는 0 내지 4의 정수이고,
c가 2 이상일 경우, 2 이상의 R3는 서로 같거나 상이하며,
*는 상기 화학식 1과 결합되는 위치이다.Compound represented by Formula 1:
[Formula 1]
In Formula 1,
R1 and R2 are the same or different from each other and are each independently hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; Or a substituted or unsubstituted aryl group having 6 to 60 carbon atoms,
Either Az1 or Az2 is -L10-Ar1, and the other is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; Or a substituted or unsubstituted aryl group having 6 to 60 carbon atoms,
L1, L2 and L10 are the same or different from each other and are each independently directly bonded; Or a substituted or unsubstituted arylene group having 6 to 60 carbon atoms,
Ar1 is a substituted or unsubstituted aryl group having 6 to 60 carbon atoms,
Ar2 is a substituted or unsubstituted aryl group having 6 to 60 carbon atoms; Or, it is a substituted or unsubstituted heterocyclic group having 2 to 60 carbon atoms containing one or more of O, S, and N,
a is an integer from 0 to 5, b is an integer from 0 to 6,
When a is 2 or more, 2 or more R1s are the same or different from each other,
When b is 2 or more, 2 or more R2s are the same or different from each other,
* combines with Formula 2 below,
[Formula 2]
In Formula 2,
X is O, S, NR, or CR'R",
R, R', R" and R3 are the same or different from each other, and each independently represents hydrogen; deuterium; a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; or a substituted or unsubstituted aryl group having 6 to 60 carbon atoms,
c is an integer from 0 to 4,
When c is 2 or more, 2 or more R3s are the same or different from each other,
* is the position bonded to Formula 1 above.
[화학식 1-1]
[화학식 1-2]
상기 화학식 1-1 및 1-2에 있어서,
L1, L2, R1 내지 R3, Az1, Az2, Ar2, X 및 a 내지 c의 정의는 화학식 1 및 2에서와 같다.The compound according to claim 1, wherein Formula 1 is represented by the following Formula 1-1 or 1-2:
[Formula 1-1]
[Formula 1-2]
In Formulas 1-1 and 1-2,
The definitions of L1, L2, R1 to R3, Az1, Az2, Ar2, X and a to c are the same as in Formulas 1 and 2.
.The compound according to claim 1, wherein Formula 1 is selected from the following compounds:
.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200007436 | 2020-01-20 | ||
KR1020200007436 | 2020-01-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210093784A KR20210093784A (en) | 2021-07-28 |
KR102605832B1 true KR102605832B1 (en) | 2023-11-27 |
Family
ID=77126363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210007505A KR102605832B1 (en) | 2020-01-20 | 2021-01-19 | Compound and organic light emitting device comprising same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102605832B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102657637B1 (en) * | 2020-07-08 | 2024-04-15 | 주식회사 엘지화학 | Anthracene compound, coating composition and organic light emitting device comprising same |
US20240164206A1 (en) * | 2021-02-15 | 2024-05-16 | Sfc Co., Ltd. | Organic light-emitting compound and organic light-emitting device comprising same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102519269B1 (en) * | 2020-01-20 | 2023-04-10 | 주식회사 엘지화학 | Polycyclic compound and organic light emitting device comprising same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140049186A (en) * | 2012-10-16 | 2014-04-25 | 롬엔드하스전자재료코리아유한회사 | Organic electroluminescence compounds and organic electroluminescence device comprising the same |
JP6370568B2 (en) | 2014-03-14 | 2018-08-08 | 出光興産株式会社 | Ink composition, organic electroluminescence device using ink composition, and electronic apparatus |
KR102615636B1 (en) * | 2016-01-13 | 2023-12-20 | 삼성디스플레이 주식회사 | Organic light-emitting device |
KR102698886B1 (en) * | 2016-05-03 | 2024-08-28 | 삼성디스플레이 주식회사 | Organic light emitting device |
KR20180027676A (en) * | 2016-09-05 | 2018-03-15 | 삼성디스플레이 주식회사 | Organic light emitting device |
-
2021
- 2021-01-19 KR KR1020210007505A patent/KR102605832B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102519269B1 (en) * | 2020-01-20 | 2023-04-10 | 주식회사 엘지화학 | Polycyclic compound and organic light emitting device comprising same |
Also Published As
Publication number | Publication date |
---|---|
KR20210093784A (en) | 2021-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3757110B1 (en) | Heterocyclic compound and organic light-emitting device comprising same | |
KR102141284B1 (en) | Multicyclic compound and organic light emitting device comprising the same | |
KR20230074687A (en) | Organic light emitting device | |
KR102250389B1 (en) | Organic light emitting device | |
KR20210042873A (en) | Organic light emitting device | |
KR102245933B1 (en) | Organic light emitting device | |
KR102245935B1 (en) | Multicyclic compound and organic electronic device comprising same | |
CN113906582A (en) | Organic light emitting device | |
KR102616373B1 (en) | Organic electroluminescent device | |
KR102605832B1 (en) | Compound and organic light emitting device comprising same | |
KR102519269B1 (en) | Polycyclic compound and organic light emitting device comprising same | |
KR102230988B1 (en) | Compound and organic light emitting device comprising the same | |
KR102484034B1 (en) | Polycyclic compound and organic light emitting device comprising same | |
KR102552978B1 (en) | Compound and organic light emitting device comprising same | |
KR102546867B1 (en) | Organic light emitting device | |
KR102710168B1 (en) | Compound and organic light emitting device comprising same | |
KR20220125018A (en) | Compound and organic light emitting device comprising the same | |
KR102162607B1 (en) | Compound and organic light emitting device comprising the same | |
KR20220081059A (en) | Heterocyclic compound and organic light emitting device comprising the same | |
KR102223482B1 (en) | Compound and organic light emitting device comprising the same | |
KR102405389B1 (en) | Organic light emitting device | |
KR20210093790A (en) | Compound and organic light emitting device comprising the same | |
KR20180114470A (en) | Anthracene derivatives and organic light emitting device using the same | |
KR102650283B1 (en) | Compound and organic light emitting device comprising same | |
KR102629147B1 (en) | Compound and organic light emitting device comprising same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |